<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-10T16:44:39+00:00">
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-BFA-T-PADS-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Scaling-up of high impact interventions in the fight against TB based on the STOP TB strategy - Burkina Faso (01-Jul-2015-31-Dec-2017)</narrative>
    </title>
    <description type="1">
      <narrative>Burkina Faso, Tuberculosis, Programme d'Appui au Développement Sanitaire (PADS)</narrative>
    </description>
    <description type="2">
      <narrative>Goal: Reduce TB prevalence from 80 cases per 100,000 population in 2013 to 72 cases per 100,000 population in Burkina Faso by the end 2017. Objectives: Decrease TB/HIV co-infection related deaths from 19.6% (2013 cohort) to less than 5% by the end of 2017 (2016 cohort); Improve program management and strategic information availability; Increase treatment success rate of MDR-TB cases from 57.7% (2012 cohort) to at least 75% by end of 2017 (2016 cohort); Increase treatment success rate of TB cases in all forms from 79.8% (2013 cohort) to at least 90% by end of 2017 (2016 cohort).</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
    </participating-org>
    <other-identifier ref="BFA-T-PADSP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2015-07-01" />
    <activity-date type="2" iso-date="2015-07-01" />
    <activity-date type="3" iso-date="2017-12-31" />
    <activity-date type="4" iso-date="2017-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Lilian Pedrosa</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>lilian.pedrosa@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="BF" percentage="100">
      <narrative>Burkina Faso</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="100">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <transaction ref="d014fed2-0f80-48ba-b9ba-e3d366d1949f">
      <transaction-type code="2" />
      <transaction-date iso-date="2015-08-21" />
      <value currency="USD" value-date="2015-08-21">2174221.91</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c17a313f-5adf-4855-af53-5c7fd007bb6d">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-08-25" />
      <value currency="USD" value-date="2015-08-25">31101.91</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7d40cefd-e907-48ec-ac75-98ab4030ae9e">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-08-25" />
      <value currency="USD" value-date="2015-08-25">747275.89</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a1068a36-6d1b-4c54-b4a7-98d3d2deeca5">
      <transaction-type code="2" />
      <transaction-date iso-date="2015-09-09" />
      <value currency="USD" value-date="2015-09-09">-14125.98</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1e1b0b53-4d42-4932-90e8-cd9db61f5c8e">
      <transaction-type code="7" />
      <transaction-date iso-date="2015-09-09" />
      <value currency="USD" value-date="2015-09-09">14125.98</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP01.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="229fe550-8e6c-4089-9dd7-73e0fffa38ac">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-12-08" />
      <value currency="USD" value-date="2015-12-08">592827.65</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5040def9-5f31-4199-a78d-15346117f2af">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-12-21" />
      <value currency="USD" value-date="2015-12-21">527389.67</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fafa9209-0a77-4adc-a1fb-2bc63dcbbdf4">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-05-10" />
      <value currency="USD" value-date="2016-05-10">27536.00</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8711e8eb-745f-4dbb-af6b-65ff90ec21c7">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-07-12" />
      <value currency="USD" value-date="2016-07-12">-248090.78</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3df4c4b6-4873-452f-a5cb-b3580b7253d6">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-07-12" />
      <value currency="USD" value-date="2016-07-12">2610304.03</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="47cf5629-d64d-4abf-8a0e-c72629e1a170">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-07-14" />
      <value currency="USD" value-date="2016-07-14">30895.39</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6957d2d4-3eea-4e17-ab07-2c84511b7d0a">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-07-14" />
      <value currency="USD" value-date="2016-07-14">800829.25</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="14b60cef-1797-48d4-9dc8-da828cad74b4">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-12-21" />
      <value currency="USD" value-date="2016-12-21">139137.38</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a1b04934-d61a-4dfa-8146-0257c2fc3022">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-12-21" />
      <value currency="USD" value-date="2016-12-21">827471.82</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c20e6d16-f988-47a6-8dd9-c1a342c82cfa">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-02-21" />
      <value currency="USD" value-date="2017-02-21">110197.70</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="442ed2ba-a3d6-4653-9a6d-dee73aba4c37">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-06-09" />
      <value currency="USD" value-date="2017-06-09">107035.19</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="67ad64ec-5d6a-432b-8aac-863850efc6ba">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-06-13" />
      <value currency="USD" value-date="2017-06-13">26696.32</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5588249b-1ae4-4d1c-ab8a-ac5011acf68b">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-04" />
      <value currency="USD" value-date="2017-07-04">91122.20</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9491e857-d82d-4da0-850e-af33dd1c1c4a">
      <transaction-type code="7" />
      <transaction-date iso-date="2017-07-12" />
      <value currency="USD" value-date="2017-07-12">272681.75</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP01.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4a82d15b-d415-44f4-8b73-821a5e546cc0">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-07-14" />
      <value currency="USD" value-date="2017-07-14">526452.52</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f78661b3-eb19-47cf-b53a-6b7571461295">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-07-17" />
      <value currency="USD" value-date="2017-07-17">-476918.78</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="81e15aa1-67da-4f86-8bf6-70bd3a530b1f">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-18" />
      <value currency="USD" value-date="2017-07-18">258057.37</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7fa37ace-e952-485c-a9a1-78e15bdd80e6">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-07-26" />
      <value currency="USD" value-date="2017-07-26">-272681.75</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5db2c7bd-8727-43d1-97b6-8f338e872740">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-10-31" />
      <value currency="USD" value-date="2017-10-31">77398.19</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e598c226-157c-4f1b-8dda-c53cc533b5c2">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-12-14" />
      <value currency="USD" value-date="2017-12-14">38582.63</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="711ee8b8-c552-4db3-a76d-dd050be3ad01">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-12-14" />
      <value currency="USD" value-date="2017-12-14">64678.68</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6769efa4-9c22-4ca6-8d4e-c446e0df25ea">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-15" />
      <value currency="USD" value-date="2017-12-15">28869.78</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7f8297b2-63a9-4d6e-9e0f-287725a23781">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-12-15" />
      <value currency="USD" value-date="2017-12-15">28869.78</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7c2be633-031a-446b-a837-e950664e7948">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-12-18" />
      <value currency="USD" value-date="2018-12-18">-87735.66</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/BFA-T-PADS" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-10" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="53" />
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="46" />
          <actual value="29" />
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="57" />
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="57" />
          <actual value="32" />
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="68" />
          <actual value="27" />
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="68" />
          <actual value="36" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="34" />
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="46" />
          <actual value="16" />
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="57" />
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="57" />
          <actual value="20" />
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="68" />
          <actual value="30" />
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="68" />
          <actual value="30" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="49.3">
          <comment>
            <narrative>Numerator: 285; Denominator: 578.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 223; Denominator: 223.</narrative>
            </comment>
          </target>
          <actual value="80.7">
            <comment>
              <narrative>Numerator: 205; Denominator: 254.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 245; Denominator: 245.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 245; Denominator: 245.</narrative>
            </comment>
          </target>
          <actual value="63.7">
            <comment>
              <narrative>Numerator: 151; Denominator: 237.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 268; Denominator: 268.</narrative>
            </comment>
          </target>
          <actual value="37.6">
            <comment>
              <narrative>Numerator: 83; Denominator: 221.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 268; Denominator: 268.</narrative>
            </comment>
          </target>
          <actual value="84.7">
            <comment>
              <narrative>Numerator: 199; Denominator: 235.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among key affected populations/high risk groups</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among key affected populations/high risk groups</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 743; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 458.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 89.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 901.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 901.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 221.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1011.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 232.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1011.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 476.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="5545" />
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="2860" />
          <actual value="2711" />
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="3139" />
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="3139" />
          <actual value="2677" />
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="3432" />
          <actual value="3036" />
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="3432" />
          <actual value="2582" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="81.4">
          <comment>
            <narrative>Numerator: 70; Denominator: 86.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 90; Denominator: 90.</narrative>
            </comment>
          </target>
          <actual value="95.3">
            <comment>
              <narrative>Numerator: 82; Denominator: 86.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 95; Denominator: 95.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 100; Denominator: 100.</narrative>
            </comment>
          </target>
          <actual value="93.3">
            <comment>
              <narrative>Numerator: 83; Denominator: 89.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 105; Denominator: 105.</narrative>
            </comment>
          </target>
          <actual value="71.9">
            <comment>
              <narrative>Numerator: 64; Denominator: 89.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 110; Denominator: 110.</narrative>
            </comment>
          </target>
          <actual value="79.4">
            <comment>
              <narrative>Numerator: 50; Denominator: 63.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31" value="79.7">
          <comment>
            <narrative>Numerator: 4245; Denominator: 5326.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="87">
            <comment>
              <narrative>Numerator: 4976; Denominator: 5720.</narrative>
            </comment>
          </target>
          <actual value="80.7">
            <comment>
              <narrative>Numerator: 4672; Denominator: 5792.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 2825; Denominator: 3139.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 5649; Denominator: 6277.</narrative>
            </comment>
          </target>
          <actual value="77.9">
            <comment>
              <narrative>Numerator: 4540; Denominator: 5825.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 3089; Denominator: 3432.</narrative>
            </comment>
          </target>
          <actual value="79.1">
            <comment>
              <narrative>Numerator: 2462; Denominator: 3113.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 6178; Denominator: 6864.</narrative>
            </comment>
          </target>
          <actual value="80.1">
            <comment>
              <narrative>Numerator: 4436; Denominator: 5539.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive patients who were screened for TB in HIV care or treatment settings</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive patients who were screened for TB in HIV care or treatment settings</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="65.7">
          <comment>
            <narrative>Numerator: 18166; Denominator: 27629.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="68">
            <comment>
              <narrative>Numerator: 45342; Denominator: 66680.</narrative>
            </comment>
          </target>
          <actual value="0">
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="73">
            <comment>
              <narrative>Numerator: 52427; Denominator: 71817.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="73">
            <comment>
              <narrative>Numerator: 53965; Denominator: 73925.</narrative>
            </comment>
          </target>
          <actual value="57.7">
            <comment>
              <narrative>Numerator: 38277; Denominator: 66366.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="75">
            <comment>
              <narrative>Numerator: 58392; Denominator: 77857.</narrative>
            </comment>
          </target>
          <actual value="69.6">
            <comment>
              <narrative>Numerator: 37518; Denominator: 53864.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="75">
            <comment>
              <narrative>Numerator: 60106; Denominator: 80141.</narrative>
            </comment>
          </target>
          <actual value="65.8">
            <comment>
              <narrative>Numerator: 33414; Denominator: 50782.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31" value="82.8">
          <comment>
            <narrative>Numerator: 564; Denominator: 681.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="83.4">
            <comment>
              <narrative>Numerator: 236; Denominator: 283.</narrative>
            </comment>
          </target>
          <actual value="90.1">
            <comment>
              <narrative>Numerator: 281; Denominator: 312.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="88.4">
            <comment>
              <narrative>Numerator: 222; Denominator: 251.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="88.4">
            <comment>
              <narrative>Numerator: 222; Denominator: 251.</narrative>
            </comment>
          </target>
          <actual value="93.6">
            <comment>
              <narrative>Numerator: 236; Denominator: 252.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="92.9">
            <comment>
              <narrative>Numerator: 195; Denominator: 210.</narrative>
            </comment>
          </target>
          <actual value="92.1">
            <comment>
              <narrative>Numerator: 290.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="92.9">
            <comment>
              <narrative>Numerator: 195; Denominator: 210.</narrative>
            </comment>
          </target>
          <actual value="93.5">
            <comment>
              <narrative>Numerator: 217; Denominator: 232.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="95.9">
          <comment>
            <narrative>Numerator: 5553; Denominator: 5792.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="98">
            <comment>
              <narrative>Numerator: 3021; Denominator: 3083.</narrative>
            </comment>
          </target>
          <actual value="97">
            <comment>
              <narrative>Numerator: 2800; Denominator: 2886.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="99">
            <comment>
              <narrative>Numerator: 3350; Denominator: 3384.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="99">
            <comment>
              <narrative>Numerator: 3350; Denominator: 3384.</narrative>
            </comment>
          </target>
          <actual value="94.3">
            <comment>
              <narrative>Numerator: 2633; Denominator: 2793.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 3700; Denominator: 3700.</narrative>
            </comment>
          </target>
          <actual value="94.3">
            <comment>
              <narrative>Numerator: 2983; Denominator: 3164.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 3700; Denominator: 3700.</narrative>
            </comment>
          </target>
          <actual value="99.1">
            <comment>
              <narrative>Numerator: 2482; Denominator: 2505.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-BFA-T-PADS-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Scaling-up of high impact interventions in the fight against TB based on the STOP TB strategy - Burkina Faso (01-Jan-2018-31-Dec-2020)</narrative>
    </title>
    <description type="1">
      <narrative>Burkina Faso, Tuberculosis, Programme d'Appui au Développement Sanitaire (PADS)</narrative>
    </description>
    <description type="2">
      <narrative>Goal: Réduire l'incidence des nouveaux cas et rechutes de 52 cas pour 100 000 habitants en 2015 à 35 cas pour 100 000 habitants au Burkina Faso d’ici fin 2022. Objectives: Augmenter le taux de  succès au traitement des cas de tuberculose toutes formes confondues de 78,2% (cohorte 2015) à au moins 90% en fin 2022 (cohorte 2021); Augmenter le taux de succès du traitement des cas de TB-MR de 69,7% (cohorte 2015 régime court) à au moins 80% en fin 2022 (cohorte 2021 regime court); Diminuer le taux de décès chez les patients co-infectés TB/VIH de 17,3% (cohorte 2015) à moins de 5% en fin 2022 (cohorte 2021); Améliorer la gestion du Programme et la disponibilité de l’information stratégique.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
    </participating-org>
    <other-identifier ref="BFA-T-PADSP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2018-01-01" />
    <activity-date type="2" iso-date="2018-01-01" />
    <activity-date type="3" iso-date="2020-12-31" />
    <activity-date type="4" iso-date="2020-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Lilian Pedrosa</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>lilian.pedrosa@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="BF" percentage="100">
      <narrative>Burkina Faso</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="83.56">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="16.44">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="955f4722-71fb-4b46-8bd2-2d741fdad76b" percentage="2.46">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e07bbbe4-54fa-4084-a6fe-7f1c9c3b77b6" percentage="4">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="c9a33ca8-7a81-4232-9a19-1315956af36c" percentage="8.16">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="5221e091-6641-4eee-b68d-9b5879a96a78" percentage="0.36">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="41f514b1-2e70-4f77-98c1-68e6052dc6a9" percentage="1.23">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="054acddf-7eaa-4d8d-b6a4-97e7f6a59a1e" percentage="0.24">
        <description>
          <narrative>RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; Capacity building for health workers, including those at community level</narrative>
        </description>
      </budget-item>
      <budget-item code="1c7b99cb-f18c-499f-a55d-f7a0d6b99b21" percentage="12.7">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="5def6266-3379-441d-b565-1d99bde3edd1" percentage="0.18">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Prevention (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="3637a37c-6acc-4a5b-b7e4-00640fd7e2ec" percentage="9.96">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="f7014493-22e9-4c03-96d0-144fbb3a254f" percentage="36.06">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="1a563d22-2c21-4f9a-b142-805695850ac9" percentage="1.13">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="56afe3f2-1fa3-4fd3-b845-9ea07f4bfd51" percentage="0.68">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="accfbf9b-023f-4bd8-b952-bf1cb13e8e9b" percentage="3.72">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="edbef7da-ca99-4741-8ce0-ea3ba6cd3d3b" percentage="12.88">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="92e11022-488c-4948-abb3-b61f3d9ca4f6" percentage="6.24">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2018-01-01" />
      <period-end iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-01-01">1782541.88</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2019-01-01" />
      <period-end iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-01-01">1677117.64</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2020-01-01" />
      <period-end iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-01-01">3643940.23</value>
    </budget>
    <capital-spend percentage="22.05" />
    <transaction ref="0bb985f6-3a25-4f8e-a50f-b8b86d5f7e01">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-01-17" />
      <value currency="USD" value-date="2018-01-17">4373826.69</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0241e51f-1fa5-47a9-8259-d03f1be2e049">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-01-18" />
      <value currency="USD" value-date="2018-01-18">514422.29</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e9c04772-9691-40b3-a826-218235dd5926">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-03-19" />
      <value currency="USD" value-date="2018-03-19">22870.61</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="83befa75-4c10-4a54-a4cd-e4debe76bf35">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-04-12" />
      <value currency="USD" value-date="2018-04-12">3026.08</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1c1c00a5-2205-4a9a-ab97-ba6d91135747">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-05-17" />
      <value currency="USD" value-date="2018-05-17">206385.41</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="28b57721-9501-47bd-9c7b-24d5e8320048">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-06-19" />
      <value currency="USD" value-date="2018-06-19">142296.58</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ddbcff00-6b68-4f5c-be11-f68d2dd98a01">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-06-29" />
      <value currency="USD" value-date="2018-06-29">147636.97</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="190aae87-1dc4-4bfc-aed5-9b9272ff9e60">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-07-06" />
      <value currency="USD" value-date="2018-07-06">320903.38</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="feb27520-4951-437c-b496-033c6cd14d5b">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-07-31" />
      <value currency="USD" value-date="2018-07-31">507272.29</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5aec2e80-d9d7-42ba-85fe-b2f309c071ac">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-09-04" />
      <value currency="USD" value-date="2018-09-04">894.67</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c1765de8-812a-4334-9320-727be6e2bb23">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-11-08" />
      <value currency="USD" value-date="2018-11-08">253909.77</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f9f9f1cb-a5d3-4f62-87e3-176175ca8d84">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-11-08" />
      <value currency="USD" value-date="2018-11-08">4592.75</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b71bcb05-0d28-4fb6-945c-b2056d539875">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-11-08" />
      <value currency="USD" value-date="2018-11-08">98490.17</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d43f2902-03ab-4198-8c37-47cefe8f9fa9">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-04-23" />
      <value currency="USD" value-date="2019-04-23">628619.02</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f6e05c3b-edc2-43c5-acd6-2efc695ce237">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-05-07" />
      <value currency="USD" value-date="2019-05-07">47942.15</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1ca0c477-584b-4fd5-9eea-ff93514df1af">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-05-07" />
      <value currency="USD" value-date="2019-05-07">-22870.61</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bd15d416-b915-49e5-a9ee-0345c69a9117">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-06-14" />
      <value currency="USD" value-date="2019-06-14">24880.77</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="138895fb-bb12-46d4-a5c8-aebc213ba5a5">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-06-18" />
      <value currency="USD" value-date="2019-06-18">428896.91</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a1a6d7ef-9536-4057-8e9f-2f12ead4f13c">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-06-27" />
      <value currency="USD" value-date="2019-06-27">161022.92</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9584a81f-3aa5-4726-9470-0947a9c33ad6">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-09-25" />
      <value currency="USD" value-date="2019-09-25">-955457.48</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="703dac7f-2895-48c8-99ca-647e0009a0f6">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-09-25" />
      <value currency="USD" value-date="2019-09-25">2976400.58</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4d0c9484-b17e-4aa5-8d1f-a6e7394d3506">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-09-26" />
      <value currency="USD" value-date="2019-09-26">397498.64</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="73353b5b-6f13-42c6-8d05-7c3d8a0f7046">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-09-26" />
      <value currency="USD" value-date="2019-09-26">2787.69</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bf1b09e4-308a-4c88-8b90-b58e2d1a31f7">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-10-10" />
      <value currency="USD" value-date="2019-10-10">25540.05</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3193a259-9ee5-49ef-82a6-9a09255bdd89">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-10-26" />
      <value currency="USD" value-date="2019-10-26">-2478.67</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="04b53c58-3099-463e-915b-59612d7c354f">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-10-26" />
      <value currency="USD" value-date="2019-10-26">-23061.38</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2c4d32fb-39d6-475c-a6b1-16ab889fe49a">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-10-26" />
      <value currency="USD" value-date="2019-10-26">25540.05</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="dd91fad2-a8fc-40f8-b3df-bc8ee54f88dc">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-13" />
      <value currency="USD" value-date="2020-02-13">368107.36</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6460b339-9813-4fd5-aaf0-7bb3a0268a1f">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-13" />
      <value currency="USD" value-date="2020-02-13">320988.04</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7d402999-688d-4281-9eee-d0a7a3b981ea">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-03-26" />
      <value currency="USD" value-date="2020-03-26">3488.97</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="abe40d90-0a5b-4dc4-b0fd-e65a46959916">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-04-02" />
      <value currency="USD" value-date="2020-04-02">960012.20</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1d359178-0c66-4bdb-a2a1-fee9e26f9651">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-05" />
      <value currency="USD" value-date="2020-05-05">25653.69</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="41bb2b0a-bb60-4841-b86d-c5d8e744ed5e">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-12" />
      <value currency="USD" value-date="2020-05-12">764820.42</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2e42c0a7-4d4d-4d17-9cef-cfb05135c25b">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-12" />
      <value currency="USD" value-date="2020-05-12">-923517.69</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="eaccf2c0-36e8-4d26-9ab5-01554e0a4d13">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-14" />
      <value currency="USD" value-date="2020-05-14">698483.20</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="af0a251a-3b77-48e0-90e0-bcc0c47cf6f0">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-07-21" />
      <value currency="USD" value-date="2020-07-21">-764820.42</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="024b770f-61b9-4952-89bb-525631b6be5a">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-07-21" />
      <value currency="USD" value-date="2020-07-21">767717.54</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7ec1e2e6-e780-4dc3-ae43-5aebaf8302b6">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-07-29" />
      <value currency="USD" value-date="2020-07-29">431054.99</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="71f61519-0236-45a7-8f23-61244ba76ae7">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-09-16" />
      <value currency="USD" value-date="2020-09-16">4311.49</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6371afe4-a086-45a1-9aca-3afc1393160a">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-10-27" />
      <value currency="USD" value-date="2020-10-27">609056.76</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="a2d8eb72-0b03-4548-bea7-b7ff73c1bebd">
      <transaction-type code="7" />
      <transaction-date iso-date="2020-11-23" />
      <value currency="USD" value-date="2020-11-23">70227.29</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP02 (Government).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4ca443ad-14d3-4a43-b348-e97c2f073baf">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-11-27" />
      <value currency="USD" value-date="2020-11-27">-70227.29</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6e719c7c-06e3-4cc5-ae44-ecb355bc1047">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-11-27" />
      <value currency="USD" value-date="2020-11-27">23528.50</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="eb642034-f0a1-472a-82b5-a473b3a90919">
      <transaction-type code="7" />
      <transaction-date iso-date="2020-12-08" />
      <value currency="USD" value-date="2020-12-08">58517.06</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP02 (Government).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9fd1155b-2808-4b48-ba5c-4871673568b7">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-12-11" />
      <value currency="USD" value-date="2020-12-11">-58517.06</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8a0c4c6d-f0ab-4aa1-b5d5-1bb1a68527ef">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-06" />
      <value currency="USD" value-date="2021-04-06">89426.44</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="04b15521-4710-4ddf-8b84-52393c366f9e">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-09-01" />
      <value currency="USD" value-date="2021-09-01">4748.85</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f210053e-ee7c-4d39-81e7-e43ba8486e94">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-09-28" />
      <value currency="USD" value-date="2021-09-28">-4748.85</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="25f4ffcb-1ad0-499c-95fa-22709a6718aa">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-10-01" />
      <value currency="USD" value-date="2021-10-01">5338.79</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="77807772-9128-484a-950b-167d1526240c">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-12" />
      <value currency="USD" value-date="2021-10-12">-5338.79</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="446648c7-f5ce-436e-be5f-0f506a37ffa5">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-06-14" />
      <value currency="USD" value-date="2022-06-14">-332351.06</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fea1c967-660a-4e11-95d9-e43c3ecec8ff">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-04-09" />
      <value currency="USD" value-date="2024-04-09">225196.87</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP02 (Government).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5cf0a234-62c5-4999-a217-2d5944fa6125">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-04-12" />
      <value currency="USD" value-date="2024-04-12">-225196.87</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7b8dd46d-fdac-4b56-aaf8-9dcd303e3a87">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-07-02" />
      <value currency="USD" value-date="2024-07-02">75065.63</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP02 (Government).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fdb87853-0298-4c3a-8997-da079cb1fe23">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-05" />
      <value currency="USD" value-date="2024-07-05">-75065.63</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5230666f-ebbc-499f-bb21-b8492044105b">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-10-01" />
      <value currency="USD" value-date="2024-10-01">874.49</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP02 (Government).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="893253a2-0f6c-4dd3-9129-ea5c3658cc55">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-10-04" />
      <value currency="USD" value-date="2024-10-04">-874.49</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="BFA-T-PADSP02-EXP-20181231">
      <transaction-type code="4" />
      <transaction-date iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-12-31">1847202.21</value>
      <description>
        <narrative>Expenditure reported by Programme d'Appui au Développement Sanitaire (PADS) for BFA-T-PADSP02, Jan 2018 to Dec 2018.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
    </transaction>
    <transaction ref="BFA-T-PADSP02-EXP-20191231">
      <transaction-type code="4" />
      <transaction-date iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-12-31">1677117.66</value>
      <description>
        <narrative>Expenditure reported by Programme d'Appui au Développement Sanitaire (PADS) for BFA-T-PADSP02, Jan 2019 to Dec 2019.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
    </transaction>
    <transaction ref="BFA-T-PADSP02-EXP-20201231">
      <transaction-type code="4" />
      <transaction-date iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-12-31">2674079.52</value>
      <description>
        <narrative>Expenditure reported by Programme d'Appui au Développement Sanitaire (PADS) for BFA-T-PADSP02, Jan 2020 to Dec 2020.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
    </transaction>
    <transaction ref="BFA-T-PADSP02-EXP-20210630">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-06-30" />
      <value currency="USD" value-date="2021-06-30">127253.07</value>
      <description>
        <narrative>Expenditure reported by Programme d'Appui au Développement Sanitaire (PADS) for BFA-T-PADSP02, Jan 2021 to Jun 2021.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/BFA-T-PADS" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-10" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31">
          <comment>
            <narrative>Numerator: 58.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 37; Denominator: 58; Percentage: 0.64%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 4; Denominator: 58; Percentage: 0.07%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 10; Denominator: 58; Percentage: 0.17%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 48; Denominator: 58; Percentage: 0.83%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 42.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 42.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 84.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 102; Percentage: 120%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 52.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 33.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 105.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 74.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 65.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 25.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 131.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 68.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 68; Denominator: 68; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 14; Denominator: 68; Percentage: 20.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 54; Denominator: 68; Percentage: 79.4%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 33; Denominator: 41; Percentage: 0.8%.</narrative>
          </comment>
        </baseline>
        <baseline year="2015" iso-date="2015-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 23; Denominator: 33; Percentage: 0.7%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <comment>
            <narrative>Numerator: 41.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 37; Denominator: 41; Percentage: 0.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 4; Denominator: 41; Percentage: 0.1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 8; Denominator: 41; Percentage: 0.2%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 33; Denominator: 41; Percentage: 0.8%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 42.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 31.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 84.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 87; Percentage: 104%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 52.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 35.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 105.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 59.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 65.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 19.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 131.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 60.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 60; Denominator: 60; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 60; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 11; Denominator: 60; Percentage: 18.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 49; Denominator: 60; Percentage: 81.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 60; Denominator: 60; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 60; Denominator: 60; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="56.2">
          <comment>
            <narrative>Numerator: 245; Denominator: 436.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 224; Denominator: 224.</narrative>
            </comment>
          </target>
          <actual value="95.7">
            <comment>
              <narrative>Numerator: 156; Denominator: 163.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 448; Denominator: 448.</narrative>
            </comment>
          </target>
          <actual value="84.5">
            <comment>
              <narrative>Numerator: 371; Denominator: 439.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 199; Denominator: 199.</narrative>
            </comment>
          </target>
          <actual value="79.4">
            <comment>
              <narrative>Numerator: 108; Denominator: 136.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 399; Denominator: 399.</narrative>
            </comment>
          </target>
          <actual value="72.2">
            <comment>
              <narrative>Numerator: 241; Denominator: 334.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 173; Denominator: 173.</narrative>
            </comment>
          </target>
          <actual value="50">
            <comment>
              <narrative>Numerator: 75; Denominator: 150.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 346; Denominator: 346.</narrative>
            </comment>
          </target>
          <actual value="87.3">
            <comment>
              <narrative>Numerator: 441; Denominator: 505.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31">
          <comment>
            <narrative>Numerator: 494.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Target / Risk population group" value="Others" />
          <comment>
            <narrative>Numerator: 489; Denominator: 494.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 296.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 308.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 593.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1047; Percentage: 120%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 356.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 201.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 711.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 695.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 426.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 553.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 854.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 824.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Others" />
            <comment>
              <narrative>Numerator: 824.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31">
          <comment>
            <narrative>Numerator: 19.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 10.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 22.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 23.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 65; Percentage: 120%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 14.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 21.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 27.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 65.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 17.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 18.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 33.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 49.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31">
          <comment>
            <narrative>Numerator: 5671.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5369; Denominator: 5671.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 187; Denominator: 5671.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 3805; Denominator: 5671.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1625; Denominator: 5671.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3931; Denominator: 5671.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 4595; Denominator: 5671.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 584; Denominator: 5671.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 492; Denominator: 5671.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2912.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2823.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 5825.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5971; Percentage: 103%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3005.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2832.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6011.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5916.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3125.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2149.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6251.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5920.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 5720; Denominator: 5920; Percentage: 96.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 200; Denominator: 5920; Percentage: 3.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 3838; Denominator: 5920; Percentage: 64.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1622; Denominator: 5920; Percentage: 27.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 4298; Denominator: 5920; Percentage: 72.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 4988; Denominator: 5920; Percentage: 84.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 508; Denominator: 5920; Percentage: 8.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 424; Denominator: 5920; Percentage: 7.2%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="93.3">
          <comment>
            <narrative>Numerator: 83; Denominator: 89.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 97; Denominator: 97.</narrative>
            </comment>
          </target>
          <actual value="52.7">
            <comment>
              <narrative>Numerator: 48; Denominator: 91.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 102; Denominator: 102.</narrative>
            </comment>
          </target>
          <actual value="85.3">
            <comment>
              <narrative>Numerator: 81; Denominator: 95.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 102; Denominator: 102.</narrative>
            </comment>
          </target>
          <actual value="1.8">
            <comment>
              <narrative>Numerator: 2; Denominator: 109.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 106; Denominator: 106.</narrative>
            </comment>
          </target>
          <actual value="67">
            <comment>
              <narrative>Numerator: 65; Denominator: 97.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 106; Denominator: 106.</narrative>
            </comment>
          </target>
          <actual value="49.5">
            <comment>
              <narrative>Numerator: 48; Denominator: 97.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 108; Denominator: 108.</narrative>
            </comment>
          </target>
          <actual value="73.7">
            <comment>
              <narrative>Numerator: 73; Denominator: 99.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="78.2">
          <comment>
            <narrative>Numerator: 4320; Denominator: 5524.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="83">
            <comment>
              <narrative>Numerator: 2684; Denominator: 3234.</narrative>
            </comment>
          </target>
          <actual value="79.6">
            <comment>
              <narrative>Numerator: 2360; Denominator: 2963.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="83">
            <comment>
              <narrative>Numerator: 5368; Denominator: 6468.</narrative>
            </comment>
          </target>
          <actual value="79.3">
            <comment>
              <narrative>Numerator: 4627; Denominator: 5836.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="85">
            <comment>
              <narrative>Numerator: 2475; Denominator: 2912.</narrative>
            </comment>
          </target>
          <actual value="82.8">
            <comment>
              <narrative>Numerator: 1283; Denominator: 1549.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="85">
            <comment>
              <narrative>Numerator: 4951; Denominator: 5825.</narrative>
            </comment>
          </target>
          <actual value="84">
            <comment>
              <narrative>Numerator: 4917; Denominator: 5853.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="87">
            <comment>
              <narrative>Numerator: 2614; Denominator: 3005.</narrative>
            </comment>
          </target>
          <actual value="68.6">
            <comment>
              <narrative>Numerator: 1943; Denominator: 2832.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="87">
            <comment>
              <narrative>Numerator: 5228; Denominator: 6011.</narrative>
            </comment>
          </target>
          <actual value="77.7">
            <comment>
              <narrative>Numerator: 4601; Denominator: 5918.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="92.6">
          <comment>
            <narrative>Numerator: 477; Denominator: 515.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 343; Denominator: 343.</narrative>
            </comment>
          </target>
          <actual value="93">
            <comment>
              <narrative>Numerator: 252; Denominator: 271.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 686; Denominator: 686.</narrative>
            </comment>
          </target>
          <actual value="91.1">
            <comment>
              <narrative>Numerator: 448; Denominator: 492.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 291; Denominator: 291.</narrative>
            </comment>
          </target>
          <actual value="93.9">
            <comment>
              <narrative>Numerator: 124; Denominator: 132.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 583; Denominator: 583.</narrative>
            </comment>
          </target>
          <actual value="99.6">
            <comment>
              <narrative>Numerator: 455; Denominator: 457.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 300; Denominator: 300.</narrative>
            </comment>
          </target>
          <actual value="90">
            <comment>
              <narrative>Numerator: 135; Denominator: 150.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 601; Denominator: 601.</narrative>
            </comment>
          </target>
          <actual value="85.1">
            <comment>
              <narrative>Numerator: 361; Denominator: 424.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="89.7">
          <comment>
            <narrative>Numerator: 5087; Denominator: 5671.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 2912; Denominator: 2912.</narrative>
            </comment>
          </target>
          <actual value="88">
            <comment>
              <narrative>Numerator: 2608; Denominator: 2963.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 5825; Denominator: 5825.</narrative>
            </comment>
          </target>
          <actual value="92.4">
            <comment>
              <narrative>Numerator: 5518; Denominator: 5971.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 3005; Denominator: 3005.</narrative>
            </comment>
          </target>
          <actual value="94.1">
            <comment>
              <narrative>Numerator: 1519; Denominator: 1614.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 6011; Denominator: 6011.</narrative>
            </comment>
          </target>
          <actual value="89.5">
            <comment>
              <narrative>Numerator: 5294; Denominator: 5916.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 3125; Denominator: 3125.</narrative>
            </comment>
          </target>
          <actual value="96.3">
            <comment>
              <narrative>Numerator: 2070; Denominator: 2149.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 6251; Denominator: 6251.</narrative>
            </comment>
          </target>
          <actual value="91.4">
            <comment>
              <narrative>Numerator: 5412; Denominator: 5920.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-10T16:44:39+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-BFA-T-PADS-3</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Scaling-up of high impact interventions in the fight against TB - Burkina Faso (01-Jan-2021-31-Dec-2023)</narrative>
    </title>
    <description type="1">
      <narrative>Burkina Faso, Tuberculosis, Programme d'Appui au Développement Sanitaire (PADS)</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Contribuer à l’amélioration de l’état de santé de la population du Burkina Faso en réduisant le poids de la tuberculose d’ici à fin 2025.  To contribute to the improvement of the health status of the population of Burkina Faso by reducing the burden of tuberculosis by the end of 2025; Réduire l’incidence de la tuberculose de 48 en 2018 à 40 cas/100 000 habitants en 2025 et le taux de mortalité de 7,8 à 5,7 décès/100 000 habitants d’ici à fin 2025.  Reduce the incidence of tuberculosis from 48 in 2018 to 40 cases/100,000 inhabitants in 2025 and the mortality rate from 7.8 to 5.7 deaths/100,000 inhabitants by the end of 2025. Objectives: Diagnostiquer et mettre sous traitement 40 641 malades TB de 2021 à 2025 avec une augmentation du taux de couverture du traitement de la TB (notifiés/incidence estimée) de 63% en 2018 à 90% en 2025.  To diagnose and treat 40,641 TB patients from 2021 to 2025 with an increase in TB treatment coverage (reported/estimated incidence) from 63% in 2018 to 90% in 2025; Augmenter la proportion des nouveaux patients et rechutes de TB toutes formes ayant bénéficié du test Xpert MTB/RIF en diagnostic initial de 21 % en 2018 à 98% en 2025.  To increase the proportion of new patients and relapses of all forms of TB having benefited from the Xpert MTB/RIF test in initial diagnosis from 21% in 2018 to 98% in 2025; Accroître le taux de succès au traitement des patients TB pharmaco sensibles de 79,1% (cohorte 2018) à au moins 90% (cohorte 2024) et ceux TB-résistante de 61,8% (cohorte 2018) à au moins 85% (cohorte 2024); Réduire le taux de décès chez les patients TB/VIH de 20% (cohorte 2018) à moins de 5% (cohorte 2024) .  Reduce the death rate among TB/HIV patients from 20% (cohort 2018) to less than 5% (cohort 2024); Assurer le traitement antituberculeux à 100% des patients TB des zones à déficit sécuritaire.  Ensuring 100% TB treatment for TB patients in unsafe areas; Renforcer les capacités du PNT dans la gestion de la lutte contre la tuberculose d’ici à fin 2025.  Strengthen the capacity of the NTP in the management of tuberculosis control by the end of 2025.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
    </participating-org>
    <other-identifier ref="BFA-T-PADSP03" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="3" />
    <activity-date type="1" iso-date="2021-01-01" />
    <activity-date type="2" iso-date="2021-01-01" />
    <activity-date type="3" iso-date="2023-12-31" />
    <activity-date type="4" iso-date="2023-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Lilian Pedrosa</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>lilian.pedrosa@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="BF" percentage="100">
      <narrative>Burkina Faso</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="74.65">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="25.35">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="6a7cb452-4c5d-49b6-aa43-8437d24fa1c5" percentage="12.73">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="31a8e187-9648-42f5-a520-92e7e53d4ac6" percentage="6.73">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="c9e8bc4a-398e-4c4b-afbb-cf98965f552e" percentage="0.81">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="d110361a-331b-4f72-bd32-016450445cc3" percentage="2.73">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="7d2483ee-e340-40e2-8f81-88b761c385aa" percentage="0.32">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="b235c58e-3a80-49b8-aeb9-ddaad2b16768" percentage="2.02">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="8194063f-1bf8-4be2-9ebd-2823d5ac44a3" percentage="9.79">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="a93b0a8f-4b2d-4b43-806e-06b2f2240144" percentage="39.18">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="70cce1e1-1248-426c-b949-2fe2feec2c0a" percentage="0.37">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key Populations (TB care and prevention) - Children</narrative>
        </description>
      </budget-item>
      <budget-item code="2b47e4dd-6430-4bc5-829c-127bb93a72a8" percentage="18.1">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2a4026f0-ad81-4b0f-9cfb-c54a725ea0ea" percentage="0.23">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Collaborative activities with other programs and sectors (TB/HIV)</narrative>
        </description>
      </budget-item>
      <budget-item code="3844a48b-ee6f-484c-866d-4d19de42ce72" percentage="0.25">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Community TB/HIV care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="0a98545b-3bce-45e8-a655-e8c11846bf1b" percentage="1.16">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Key populations (TB/HIV) - Miners and mining communities</narrative>
        </description>
      </budget-item>
      <budget-item code="09e971e9-8dcf-496e-91a5-0bfc6e27b547" percentage="1.86">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Key populations (TB/HIV) - Mobile populations: refugees, migrants and internally displaced people</narrative>
        </description>
      </budget-item>
      <budget-item code="44258a15-355f-4a95-8f2c-662ecb266256" percentage="3.02">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Key populations (TB/HIV) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="2146ce4f-9254-4a2a-8be8-e14734ab53dc" percentage="0.61">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="d5851297-913c-4ce3-a373-c0915334727a" percentage="0.09">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Prevention</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">2428707.20</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">5227946.65</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2023-01-01" />
      <period-end iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-01-01">3701767.57</value>
    </budget>
    <capital-spend percentage="20.41" />
    <transaction ref="b1503222-6be4-4464-9500-bf71d33db9a5">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-01-12" />
      <value currency="USD" value-date="2021-01-12">6763681.56</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="93936770-e749-4ceb-b600-9fa21170445a">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-01-20" />
      <value currency="USD" value-date="2021-01-20">474246.63</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ec50b38c-f2b9-4a5d-933e-ec4bcbdb0b9a">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-02-12" />
      <value currency="USD" value-date="2021-02-12">200373.60</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="050cdb38-8a5d-49ab-9245-18ce60952e8d">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-03-19" />
      <value currency="USD" value-date="2021-03-19">942172.00</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cbbbdcca-b9c5-4b78-9652-61a95567ea26">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-06-11" />
      <value currency="USD" value-date="2021-06-11">109395.63</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1ddfd423-b78c-4a79-95dc-6fe30e606675">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-07-07" />
      <value currency="USD" value-date="2021-07-07">23111.18</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0b25bf8b-8735-45da-8310-b6c5fc00dd05">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-29" />
      <value currency="USD" value-date="2021-07-29">330971.05</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="404b77f3-efc2-4285-8788-a4964dc7b890">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-08-05" />
      <value currency="USD" value-date="2021-08-05">70811.65</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="91c08701-a457-48d5-8f93-b5b10bfc83b4">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-08-19" />
      <value currency="USD" value-date="2021-08-19">1111663.34</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="27dfd0f7-024a-4575-8071-d9b3868cdfe7">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-09-23" />
      <value currency="USD" value-date="2021-09-23">176924.68</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="84290fc0-4220-43a6-9fbe-aa496890ecf0">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-25" />
      <value currency="USD" value-date="2021-11-25">206948.34</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cdfe1c15-f5d4-4099-9c41-0dc02211d389">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-09" />
      <value currency="USD" value-date="2021-12-09">16233.01</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6d78e626-9874-424d-81ad-757aec789511">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-09" />
      <value currency="USD" value-date="2021-12-09">102262.79</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="45240d6a-0629-4830-afa7-ace0f5efbd00">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-16" />
      <value currency="USD" value-date="2021-12-16">304278.74</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fdff7651-adf3-470a-95bf-16cce3cf93e0">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-01-20" />
      <value currency="USD" value-date="2022-01-20">100313.02</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fa23741a-0919-4dd9-8b91-deff86765ee5">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-02-24" />
      <value currency="USD" value-date="2022-02-24">47650.69</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9099585a-d71f-47fd-be6a-991ce4f3f7e2">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-02-24" />
      <value currency="USD" value-date="2022-02-24">-23111.18</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="061da29e-a67c-414d-a88d-5d1247b0c571">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-01" />
      <value currency="USD" value-date="2022-03-01">24597.42</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5d5c0dc8-939a-4b09-b59b-bce77b93fb5a">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-24" />
      <value currency="USD" value-date="2022-03-24">89512.93</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0d391db4-9b43-490f-bfbd-17121c63d9e1">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-30" />
      <value currency="USD" value-date="2022-05-30">15132.83</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5cb80c6f-4c01-414b-89f5-667f4bb0e7d7">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-30" />
      <value currency="USD" value-date="2022-05-30">255363.97</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1da66b48-ead5-4f3e-a7be-bc59c791ce83">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-01" />
      <value currency="USD" value-date="2022-07-01">687894.25</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9783cddf-3529-4adf-b161-f19858a7ab01">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-01" />
      <value currency="USD" value-date="2022-07-01">269711.80</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="961b7d13-ee17-444d-8017-da6e166789bf">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-21" />
      <value currency="USD" value-date="2022-07-21">8167.37</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="856b0bbe-be52-4691-8c00-7d8627e3795d">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-22" />
      <value currency="USD" value-date="2022-09-22">8161.84</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="dfa50291-7784-4b4e-903d-2c0a7f2f4596">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-10-01" />
      <value currency="USD" value-date="2022-10-01">37249.77</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c565f935-7f37-4557-bf70-dae5d3273e64">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-19" />
      <value currency="USD" value-date="2022-10-19">3525144.57</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="54e74fde-edf1-4a3a-ac68-4c851ddc63f2">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-19" />
      <value currency="USD" value-date="2022-10-19">-1283142.11</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5384e954-59f2-4316-8757-8c1655ecaeb9">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-19" />
      <value currency="USD" value-date="2022-10-19">-37249.77</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4579a625-5eea-4987-acb0-f4930c2d53bb">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-10-20" />
      <value currency="USD" value-date="2022-10-20">550651.49</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a0c9ab52-bf6e-4438-a46a-90e975dfb6ed">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-10-20" />
      <value currency="USD" value-date="2022-10-20">79767.77</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="553503c5-7a41-46c7-a11b-97824d06b36f">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-03" />
      <value currency="USD" value-date="2022-11-03">3308.88</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bcf531ed-916b-477f-86de-24cf86cf8533">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-12-01" />
      <value currency="USD" value-date="2022-12-01">3019.47</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d6374a1d-1580-4856-8b60-358e46ad1c84">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-12-08" />
      <value currency="USD" value-date="2022-12-08">9.75</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="77c23813-7c89-443c-9f50-c20a12220742">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-12-15" />
      <value currency="USD" value-date="2022-12-15">-3019.47</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="25d6559e-0d6e-45bc-aea7-419f07690ee8">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-19" />
      <value currency="USD" value-date="2022-12-19">327124.13</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="608eb1df-4513-47dd-b8eb-6247a8e5edf0">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-12-21" />
      <value currency="USD" value-date="2022-12-21">-9.75</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="809d53ae-fc68-41a2-ae74-138ad35ecdbc">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-01-12" />
      <value currency="USD" value-date="2023-01-12">396392.53</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="393b695c-3939-4cf8-9c25-39e3eead0b00">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-01-26" />
      <value currency="USD" value-date="2023-01-26">297101.24</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="377e9343-cd88-492d-94cd-faa5b834825f">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-03-24" />
      <value currency="USD" value-date="2023-03-24">63206.94</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="73a8cf84-9a26-4238-94a9-160bbd93d61a">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-04-12" />
      <value currency="USD" value-date="2023-04-12">677.73</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cc0ee0bb-808f-46a8-b62e-15163458accb">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-04-25" />
      <value currency="USD" value-date="2023-04-25">435592.79</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e6f37e9f-a327-4810-97c6-360cf1c22906">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-04-25" />
      <value currency="USD" value-date="2023-04-25">-677.73</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c7b6b291-f90d-4640-9774-a7da377780c9">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-05-11" />
      <value currency="USD" value-date="2023-05-11">435592.79</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9812d91e-e313-4225-82a4-dc2f5af1b279">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-28" />
      <value currency="USD" value-date="2023-06-28">770976.45</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="eea6d340-f826-425d-a478-6ef6bc783f88">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-28" />
      <value currency="USD" value-date="2023-06-28">140197.17</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="22e8d228-02bc-482e-972d-4be17bc8c0e3">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-28" />
      <value currency="USD" value-date="2023-06-28">25232.39</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="10688143-35ef-4102-9306-ada6a699cc67">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-07-01" />
      <value currency="USD" value-date="2023-07-01">35127.67</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="381e26df-754b-4760-84dd-6b1db5d831d0">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-11" />
      <value currency="USD" value-date="2023-07-11">-35127.67</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c793dbdd-fa36-4796-8ed2-e5153bbbf7b7">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-20" />
      <value currency="USD" value-date="2023-07-20">39223.11</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2d266d06-a2f0-4078-9b93-d9a4bbb8768c">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-26" />
      <value currency="USD" value-date="2023-07-26">1930465.03</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f4a5ca36-b62a-465e-8f50-1824476c2d87">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-03" />
      <value currency="USD" value-date="2023-08-03">12414.27</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bd693f2b-a376-4aa3-bf2e-0bbf6920d524">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-03" />
      <value currency="USD" value-date="2023-08-03">230831.38</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e96b4315-829b-4b5f-9046-873a917f3a9d">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-15" />
      <value currency="USD" value-date="2023-08-15">12587.60</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6dd560cd-45f8-4766-9b76-0ba4a1075c03">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-15" />
      <value currency="USD" value-date="2023-08-15">328857.75</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="94e8222f-7950-4827-b08c-301f29b3aee0">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-08-28" />
      <value currency="USD" value-date="2023-08-28">25383.28</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4a87d0d7-f45f-43c4-9bab-25a5fab76665">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-08-28" />
      <value currency="USD" value-date="2023-08-28">-23053.27</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5afd5218-ae6a-416f-b801-e45b4d84cf5d">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-08-28" />
      <value currency="USD" value-date="2023-08-28">-2330.01</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b2500e4c-cb91-499d-9de8-b68d3db358c6">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-05" />
      <value currency="USD" value-date="2023-09-05">652911.91</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="191b832a-f1d5-4023-981b-ea286b857521">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-09-08" />
      <value currency="USD" value-date="2023-09-08">107.77</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d218a5c2-93c4-485b-8bbc-e374bca7c13e">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-12" />
      <value currency="USD" value-date="2023-09-12">26477.36</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0f8d8081-8a23-4825-bb03-23ca8acd27e0">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-19" />
      <value currency="USD" value-date="2023-09-19">797.14</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fc5c5cc5-dd20-49fb-9055-f0fba313fcee">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-19" />
      <value currency="USD" value-date="2023-09-19">72740.10</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="60513c68-0650-4b4c-b9f0-177b53442b87">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-19" />
      <value currency="USD" value-date="2023-09-19">-107.77</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4dc858f2-8a53-40a7-b6e5-1106e05cfa99">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-10-03" />
      <value currency="USD" value-date="2023-10-03">10360.57</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="37bca9a6-c029-4b7e-bc88-dfc5ac618214">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-12-01" />
      <value currency="USD" value-date="2023-12-01">533.60</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6b6eebb4-cee1-48ae-83e4-3ac1da383cb9">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-12-04" />
      <value currency="USD" value-date="2023-12-04">44.29</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ea2f37d4-423a-43a4-b8e2-b7c9e847cb23">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-12-12" />
      <value currency="USD" value-date="2023-12-12">619324.88</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="241bb3d6-ea90-46eb-b39d-63c028f6fc65">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-22" />
      <value currency="USD" value-date="2023-12-22">-44.29</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c6c5b2cd-8e38-4e35-b418-56dfe936484c">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-22" />
      <value currency="USD" value-date="2023-12-22">-533.60</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="afe380a2-6d65-408f-975a-08c06ba6247a">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-01-31" />
      <value currency="USD" value-date="2024-01-31">-2385.18</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f27f4683-d0e0-4a91-b05d-6feaac6c16f6">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-04-12" />
      <value currency="USD" value-date="2024-04-12">5742.97</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b97ce1aa-d421-40b9-93f9-ca1b16f0aa3d">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-04-26" />
      <value currency="USD" value-date="2024-04-26">-5742.97</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="03068231-a4a2-4920-b992-9c994f4d43f1">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-05-16" />
      <value currency="USD" value-date="2024-05-16">34.47</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bb860e2b-cae8-4fdc-82ff-b9f944e178ce">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-05-16" />
      <value currency="USD" value-date="2024-05-16">-25383.28</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f10a274b-5561-4370-9feb-118610bc11b0">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-05-22" />
      <value currency="USD" value-date="2024-05-22">17647.38</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6e0e352e-835a-4ce4-9f25-5e1b1d53611c">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-05-28" />
      <value currency="USD" value-date="2024-05-28">8541.53</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e2d6a72e-7baf-4541-bae1-fd92d6da54b4">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-07-01" />
      <value currency="USD" value-date="2024-07-01">24720.23</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1bab0390-1c07-421d-b129-24ac4c80b2c2">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-05" />
      <value currency="USD" value-date="2024-07-05">-24720.23</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4c521082-a80f-43fb-bf4c-b4961518c2ed">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-08-08" />
      <value currency="USD" value-date="2024-08-08">8587.53</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0bb62a1d-c43a-4101-af62-5e8356577abb">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-09-01" />
      <value currency="USD" value-date="2024-09-01">37306.57</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ef939ee2-3f71-479c-836a-d596ea568e98">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-09-01" />
      <value currency="USD" value-date="2024-09-01">18102.86</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="381f514c-4ef6-411e-8354-0b4fd9a0627a">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-24" />
      <value currency="USD" value-date="2024-09-24">-37306.57</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="645c2ce4-e1e0-4064-8518-8ab341ef6b07">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-27" />
      <value currency="USD" value-date="2024-09-27">-18102.86</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5c4bde09-4966-4600-8c23-caff10606ed2">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-30" />
      <value currency="USD" value-date="2024-09-30">-6508.52</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="07c3429b-77ab-4fbc-878f-10da89a49518">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-10-01" />
      <value currency="USD" value-date="2024-10-01">72918.67</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP03 (Government).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e5c18a40-dd1a-4884-843e-0a15ad31b5b7">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-10-01" />
      <value currency="USD" value-date="2024-10-01">6508.52</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5dc56ee7-ec6b-4080-88ec-ef0073f74e12">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-10-01" />
      <value currency="USD" value-date="2024-10-01">1015.58</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="db74b599-fcf0-409a-97b6-81f5091082be">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-10-04" />
      <value currency="USD" value-date="2024-10-04">-72918.67</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7f05e591-c2be-419e-bb79-5e862b96cfed">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-10-18" />
      <value currency="USD" value-date="2024-10-18">-1015.58</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e5fb9d4e-afa2-4b1c-98cc-95c34b5cf069">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-02-06" />
      <value currency="USD" value-date="2025-02-06">73778.16</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP03 (Government).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c53f0f1b-86ed-45a7-835e-06ce3a8164e7">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-02-14" />
      <value currency="USD" value-date="2025-02-14">-73778.16</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5d95a0cd-f757-4ab0-b8a3-0c3d1adcdc27">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-05-05" />
      <value currency="USD" value-date="2025-05-05">73778.16</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP03 (Government).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9bc3dea1-3f45-43cf-aa61-48e5a0968e65">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-09" />
      <value currency="USD" value-date="2025-05-09">-73778.16</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d3dc155c-3346-40e3-a360-3d74218d6e78">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-27" />
      <value currency="USD" value-date="2025-06-27">-774166.44</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="641aa1ce-7d1a-465e-a00e-e6af51e8858d">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">774166.44</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ec83c177-c7c1-47df-8674-a34b5a91fca4">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-10-15" />
      <value currency="USD" value-date="2025-10-15">73778.18</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP03 (Government).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b5901708-7440-4584-a1c1-6163d2b8d6c1">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-17" />
      <value currency="USD" value-date="2025-10-17">-73778.18</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b56399cb-518a-4824-bd28-3f82477c5b08">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-02-17" />
      <value currency="USD" value-date="2026-02-17">-518.33</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="BFA-T-PADSP03-EXP-20211231">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-12-31">2428707.29</value>
      <description>
        <narrative>Expenditure reported by Programme d'Appui au Développement Sanitaire (PADS) for BFA-T-PADSP03, Jan 2021 to Dec 2021.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
    </transaction>
    <transaction ref="BFA-T-PADSP03-EXP-20221231">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-12-31">3037111.56</value>
      <description>
        <narrative>Expenditure reported by Programme d'Appui au Développement Sanitaire (PADS) for BFA-T-PADSP03, Jan 2022 to Dec 2022.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
    </transaction>
    <transaction ref="BFA-T-PADSP03-EXP-20231231">
      <transaction-type code="4" />
      <transaction-date iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-12-31">4401565.57</value>
      <description>
        <narrative>Expenditure reported by Programme d'Appui au Développement Sanitaire (PADS) for BFA-T-PADSP03, Jan 2023 to Dec 2023.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
    </transaction>
    <transaction ref="BFA-T-PADSP03-EXP-20240630">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-06-30" />
      <value currency="USD" value-date="2024-06-30">310976.59</value>
      <description>
        <narrative>Expenditure reported by Programme d'Appui au Développement Sanitaire (PADS) for BFA-T-PADSP03, Jan 2024 to Jun 2024.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/BFA-T-PADS" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-10" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/BFA/2020/TB_HIV/en/BFA-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2020 - Funding Request - Window 2b - TB/HIV - Burkina Faso - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR940-BFA-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2020-05-31" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/BFA/2020/TB_HIV/fr/BFA-C_FundingRequest_1_fr.zip" format="application/zip">
      <title>
        <narrative>2020 - Funding Request - Window 2b - TB/HIV - Burkina Faso - Français</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR940-BFA-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="fr" />
      <document-date iso-date="2020-05-31" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 74.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 72; Denominator: 74; Percentage: 97.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 72; Denominator: 74; Percentage: 97.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 72; Denominator: 74; Percentage: 97.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 72; Denominator: 74; Percentage: 97.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 72; Denominator: 74; Percentage: 97.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 72; Denominator: 74; Percentage: 97.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 2; Denominator: 74; Percentage: 2.7%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 2; Denominator: 74; Percentage: 2.7%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 2; Denominator: 74; Percentage: 2.7%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 2; Denominator: 74; Percentage: 2.7%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 2; Denominator: 74; Percentage: 2.7%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 11; Denominator: 74; Percentage: 14.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 11; Denominator: 74; Percentage: 14.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 11; Denominator: 74; Percentage: 14.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 11; Denominator: 74; Percentage: 14.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 11; Denominator: 74; Percentage: 14.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 11; Denominator: 74; Percentage: 14.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 63; Denominator: 74; Percentage: 85.14%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 63; Denominator: 74; Percentage: 85.14%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 63; Denominator: 74; Percentage: 85.14%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 63; Denominator: 74; Percentage: 85.14%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 63; Denominator: 74; Percentage: 85.14%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 63; Denominator: 74; Percentage: 85.14%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 59.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 47; Percentage: 80%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 47.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 9.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 38.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 119.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 83.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 60.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 36; Percentage: 60%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 36.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 6.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 30.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 71.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 30.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 30.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 10.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 20.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 142.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 73.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 71.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 43.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 43.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 2.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 41.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 76.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 70.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 70.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 10.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 60.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 152.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 127.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 76.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 57.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 56.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 12.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 45.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 66.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 2; Denominator: 66; Percentage: 3.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 2; Denominator: 66; Percentage: 3.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 2; Denominator: 66; Percentage: 3.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 2; Denominator: 66; Percentage: 3.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 2; Denominator: 66; Percentage: 3.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 2; Denominator: 66; Percentage: 3.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 64; Denominator: 66; Percentage: 96.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 64; Denominator: 66; Percentage: 96.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 64; Denominator: 66; Percentage: 96.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 64; Denominator: 66; Percentage: 96.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 64; Denominator: 66; Percentage: 96.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 64; Denominator: 66; Percentage: 96.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 64; Denominator: 66; Percentage: 96.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 64; Denominator: 66; Percentage: 96.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 64; Denominator: 66; Percentage: 96.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 64; Denominator: 66; Percentage: 96.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 64; Denominator: 66; Percentage: 96.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 55; Denominator: 66; Percentage: 83.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 55; Denominator: 66; Percentage: 83.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 55; Denominator: 66; Percentage: 83.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 55; Denominator: 66; Percentage: 83.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 55; Denominator: 66; Percentage: 83.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 55; Denominator: 66; Percentage: 83.33%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 59.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 42; Percentage: 71%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 42.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 33.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 42.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 119.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 76.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 60.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 34; Percentage: 57%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 34.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 28.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 34.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 71.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 29.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 29.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 20.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 29.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 142.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 67.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 71.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 38.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 38.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 36.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 35.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 76.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 64.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 64.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 54.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 60.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 152.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 113.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 76.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 49.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 48.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 38.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 49.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 5916.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5737; Denominator: 5916; Percentage: 96.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5737; Denominator: 5916; Percentage: 96.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5737; Denominator: 5916; Percentage: 96.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5737; Denominator: 5916; Percentage: 96.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5737; Denominator: 5916; Percentage: 96.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5737; Denominator: 5916; Percentage: 96.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 179; Denominator: 5916; Percentage: 3.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 179; Denominator: 5916; Percentage: 3.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 179; Denominator: 5916; Percentage: 3.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 179; Denominator: 5916; Percentage: 3.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 179; Denominator: 5916; Percentage: 3.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 179; Denominator: 5916; Percentage: 3.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 4733; Denominator: 5916; Percentage: 80%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 4733; Denominator: 5916; Percentage: 80%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 4733; Denominator: 5916; Percentage: 80%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 4733; Denominator: 5916; Percentage: 80%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 4733; Denominator: 5916; Percentage: 80%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 4733; Denominator: 5916; Percentage: 80%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1479; Denominator: 5916; Percentage: 25%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1479; Denominator: 5916; Percentage: 25%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1479; Denominator: 5916; Percentage: 25%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1479; Denominator: 5916; Percentage: 25%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1479; Denominator: 5916; Percentage: 25%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1479; Denominator: 5916; Percentage: 25%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 4437; Denominator: 5916; Percentage: 75%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 4437; Denominator: 5916; Percentage: 75%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 4437; Denominator: 5916; Percentage: 75%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 4437; Denominator: 5916; Percentage: 75%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 4437; Denominator: 5916; Percentage: 75%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 4437; Denominator: 5916; Percentage: 75%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 4837; Denominator: 5294; Percentage: 91.37%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 4837; Denominator: 5294; Percentage: 91.37%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 4837; Denominator: 5294; Percentage: 91.37%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 4837; Denominator: 5294; Percentage: 91.37%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 4837; Denominator: 5294; Percentage: 91.37%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 4837; Denominator: 5294; Percentage: 91.37%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 622; Denominator: 5916; Percentage: 10.51%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 622; Denominator: 5916; Percentage: 10.51%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 622; Denominator: 5916; Percentage: 10.51%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 622; Denominator: 5916; Percentage: 10.51%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 622; Denominator: 5916; Percentage: 10.51%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 622; Denominator: 5916; Percentage: 10.51%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 457; Denominator: 5294; Percentage: 8.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 457; Denominator: 5294; Percentage: 8.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 457; Denominator: 5294; Percentage: 8.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 457; Denominator: 5294; Percentage: 8.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 457; Denominator: 5294; Percentage: 8.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 457; Denominator: 5294; Percentage: 8.63%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3151.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3137; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 3106.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 95.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 2082.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 798.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2486.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 2788.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 147.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 266.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6303.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6739.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3152.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3602; Percentage: 114%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 3483.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 119.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 2558.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 917.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2685.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 3298.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 114.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 190.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3394.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3121.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 3001.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 118.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 2084.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 812.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2307.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 2866.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 78.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 177.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6788.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6786.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3394.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3665.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 3555.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 110.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 2480.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 901.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2764.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 3386.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 89.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 190.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3639.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4201.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 4078.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 123.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 2695.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1023.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 3178.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 3823.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 107.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 271.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7278.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8438.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3639.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4237.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 4059.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 178.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 2974.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1058.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 3179.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 3896.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 68.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 273.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 793; Denominator: 3776; Percentage: 21%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 19; Denominator: 2492; Percentage: 0.76%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 19; Denominator: 2492; Percentage: 0.76%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 19; Denominator: 2492; Percentage: 0.76%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 19; Denominator: 2492; Percentage: 0.76%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 19; Denominator: 2492; Percentage: 0.76%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 598.77; Denominator: 1088.67; Percentage: 55%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 846; Denominator: 1089; Percentage: 77.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 862; Denominator: 1161; Percentage: 74.2%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1197.8; Denominator: 2177.7; Percentage: 55%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1497; Denominator: 2246; Percentage: 66.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 598.96; Denominator: 1089.02; Percentage: 55%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 651; Denominator: 1157; Percentage: 56.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 820.84; Denominator: 1172.63; Percentage: 70%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 668; Denominator: 1173; Percentage: 57%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 668.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1641.6; Denominator: 2345.2; Percentage: 70%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1406; Denominator: 2137; Percentage: 65.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 820.84; Denominator: 1172.63; Percentage: 70%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 738; Denominator: 964; Percentage: 76.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 738.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1005.82; Denominator: 1257.27; Percentage: 80%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 824; Denominator: 845; Percentage: 97.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 824.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2011.6; Denominator: 2514.6; Percentage: 80%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1541; Denominator: 1613; Percentage: 95.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1005.82; Denominator: 1257.27; Percentage: 80%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 717; Denominator: 768; Percentage: 93.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 717.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="83.96">
          <comment>
            <narrative>Numerator: 89; Denominator: 106.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="94.8">
            <comment>
              <narrative>Numerator: 109; Denominator: 115.</narrative>
            </comment>
          </target>
          <actual value="92">
            <comment>
              <narrative>Numerator: 104; Denominator: 113.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="94.8">
            <comment>
              <narrative>Numerator: 109; Denominator: 115.</narrative>
            </comment>
          </target>
          <actual value="88.2">
            <comment>
              <narrative>Numerator: 105; Denominator: 119.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="94.8">
            <comment>
              <narrative>Numerator: 109; Denominator: 115.</narrative>
            </comment>
          </target>
          <actual value="88.2">
            <comment>
              <narrative>Numerator: 105; Denominator: 119.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 115; Denominator: 121.</narrative>
            </comment>
          </target>
          <actual value="51.3">
            <comment>
              <narrative>Numerator: 58; Denominator: 113.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="94.5">
            <comment>
              <narrative>Numerator: 121; Denominator: 128.</narrative>
            </comment>
          </target>
          <actual value="94.7">
            <comment>
              <narrative>Numerator: 90; Denominator: 95.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="94.53">
            <comment>
              <narrative>Numerator: 121; Denominator: 128.</narrative>
            </comment>
          </target>
          <actual value="94.7">
            <comment>
              <narrative>Numerator: 90; Denominator: 95.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="95.56">
            <comment>
              <narrative>Numerator: 129; Denominator: 135.</narrative>
            </comment>
          </target>
          <actual value="85.4">
            <comment>
              <narrative>Numerator: 82; Denominator: 96.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="95.7">
            <comment>
              <narrative>Numerator: 134; Denominator: 140.</narrative>
            </comment>
          </target>
          <actual value="96.2">
            <comment>
              <narrative>Numerator: 101; Denominator: 105.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="95.71">
            <comment>
              <narrative>Numerator: 134; Denominator: 140.</narrative>
            </comment>
          </target>
          <actual value="96.2">
            <comment>
              <narrative>Numerator: 101; Denominator: 105.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="23.99">
          <comment>
            <narrative>Numerator: 1180; Denominator: 4918.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="50">
            <comment>
              <narrative>Numerator: 1575.5; Denominator: 3151.</narrative>
            </comment>
          </target>
          <actual value="52.7">
            <comment>
              <narrative>Numerator: 1653; Denominator: 3137.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 3151.5; Denominator: 6303.</narrative>
            </comment>
          </target>
          <actual value="47.4">
            <comment>
              <narrative>Numerator: 3197; Denominator: 6739.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 1576; Denominator: 3152.</narrative>
            </comment>
          </target>
          <actual value="42.9">
            <comment>
              <narrative>Numerator: 1544; Denominator: 3602.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 4751.6; Denominator: 6788.</narrative>
            </comment>
          </target>
          <actual value="51.8">
            <comment>
              <narrative>Numerator: 3515; Denominator: 6786.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="70">
            <comment>
              <narrative>Numerator: 2375.8; Denominator: 3394.</narrative>
            </comment>
          </target>
          <actual value="36.2">
            <comment>
              <narrative>Numerator: 1130; Denominator: 3121.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 2375.8; Denominator: 3394.</narrative>
            </comment>
          </target>
          <actual value="65.1">
            <comment>
              <narrative>Numerator: 2385; Denominator: 3665.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="85">
            <comment>
              <narrative>Numerator: 3093.15; Denominator: 3639.</narrative>
            </comment>
          </target>
          <actual value="64.1">
            <comment>
              <narrative>Numerator: 2692; Denominator: 4201.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="85">
            <comment>
              <narrative>Numerator: 6186.4; Denominator: 7278.</narrative>
            </comment>
          </target>
          <actual value="69.3">
            <comment>
              <narrative>Numerator: 5848; Denominator: 8438.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="85">
            <comment>
              <narrative>Numerator: 3093.15; Denominator: 3639.</narrative>
            </comment>
          </target>
          <actual value="74.5">
            <comment>
              <narrative>Numerator: 3156; Denominator: 4237.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>TCP-other 1: Proportion of TB patients in CDTs in areas facing insecurity put on anti-TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>TCP-other 1: Proportion of TB patients in CDTs in areas facing insecurity put on anti-TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="100">
          <comment>
            <narrative>Numerator: 1469; Denominator: 1469.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 1472; Denominator: 1472.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 1545; Denominator: 1545.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 736; Denominator: 736.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 737; Denominator: 737.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 736; Denominator: 736.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 808; Denominator: 808.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 792; Denominator: 792.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 551; Denominator: 551.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 1584; Denominator: 1584.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 1889; Denominator: 1889.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 792; Denominator: 792.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 1338; Denominator: 1338.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 1698; Denominator: 1698.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 1233; Denominator: 1233.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 849; Denominator: 849.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 607; Denominator: 607.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 849; Denominator: 849.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 626; Denominator: 626.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="84.01">
          <comment>
            <narrative>Numerator: 4917; Denominator: 5853.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="90" />
          <actual value="80.6">
            <comment>
              <narrative>Numerator: 4117; Denominator: 5109.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="90" />
          <actual value="80.2">
            <comment>
              <narrative>Numerator: 1701; Denominator: 2122.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="90" />
          <actual value="80.9">
            <comment>
              <narrative>Numerator: 2416; Denominator: 2987.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="90" />
          <actual value="81.1">
            <comment>
              <narrative>Numerator: 5078; Denominator: 6260.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="90" />
          <actual value="81.5">
            <comment>
              <narrative>Numerator: 2316; Denominator: 2843.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="90" />
          <actual value="80.8">
            <comment>
              <narrative>Numerator: 2762; Denominator: 3417.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="90" />
          <actual value="82.8">
            <comment>
              <narrative>Numerator: 2763; Denominator: 3335.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90" />
          <actual value="81.8">
            <comment>
              <narrative>Numerator: 5799; Denominator: 7086.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90" />
          <actual value="80.9">
            <comment>
              <narrative>Numerator: 3036; Denominator: 3751.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="99.56">
          <comment>
            <narrative>Numerator: 455; Denominator: 457.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="99">
            <comment>
              <narrative>Numerator: 262.91; Denominator: 265.57.</narrative>
            </comment>
          </target>
          <actual value="92.5">
            <comment>
              <narrative>Numerator: 184; Denominator: 199.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="99">
            <comment>
              <narrative>Numerator: 525.9; Denominator: 531.3.</narrative>
            </comment>
          </target>
          <actual value="94.6">
            <comment>
              <narrative>Numerator: 368; Denominator: 389.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="99">
            <comment>
              <narrative>Numerator: 262.99; Denominator: 265.65.</narrative>
            </comment>
          </target>
          <actual value="96.8">
            <comment>
              <narrative>Numerator: 184; Denominator: 190.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="99">
            <comment>
              <narrative>Numerator: 566.4; Denominator: 572.</narrative>
            </comment>
          </target>
          <actual value="97.3">
            <comment>
              <narrative>Numerator: 357; Denominator: 367.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="99">
            <comment>
              <narrative>Numerator: 283.19; Denominator: 286.05.</narrative>
            </comment>
          </target>
          <actual value="97.7">
            <comment>
              <narrative>Numerator: 173; Denominator: 177.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="99">
            <comment>
              <narrative>Numerator: 283.19; Denominator: 286.05.</narrative>
            </comment>
          </target>
          <actual value="96.8">
            <comment>
              <narrative>Numerator: 184; Denominator: 190.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="99">
            <comment>
              <narrative>Numerator: 607.2; Denominator: 613.4.</narrative>
            </comment>
          </target>
          <actual value="93.2">
            <comment>
              <narrative>Numerator: 507; Denominator: 544.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="99">
            <comment>
              <narrative>Numerator: 303.63; Denominator: 306.69.</narrative>
            </comment>
          </target>
          <actual value="95.6">
            <comment>
              <narrative>Numerator: 259; Denominator: 271.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="99">
            <comment>
              <narrative>Numerator: 303.63; Denominator: 306.69.</narrative>
            </comment>
          </target>
          <actual value="90.8">
            <comment>
              <narrative>Numerator: 248; Denominator: 273.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of PLHIV on ART who initiated TB preventive therapy among those eligible during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of PLHIV on ART who initiated TB preventive therapy among those eligible during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="TPT regimen" value="1HP" />
          <comment>
            <narrative>Percentage: 68.12%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="TPT regimen" value="1HP" />
          <comment>
            <narrative>Percentage: 68.12%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="TPT regimen" value="1HP" />
          <comment>
            <narrative>Percentage: 68.12%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <comment>
            <narrative>Numerator: 896; Denominator: 8851; Percentage: 10.12%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1359; Denominator: 7768; Percentage: 17.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1641; Denominator: 7061; Percentage: 23.2%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 388; Denominator: 3884; Percentage: 9.99%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1053; Denominator: 3639; Percentage: 28.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 971; Denominator: 3884; Percentage: 25%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 588; Denominator: 3422; Percentage: 17.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="1HP" />
            <comment>
              <narrative>Numerator: 12.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1386; Denominator: 3961; Percentage: 34.99%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1169; Denominator: 3557; Percentage: 32.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="1HP" />
            <comment>
              <narrative>Numerator: 2.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2772; Denominator: 7922; Percentage: 35%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2775; Denominator: 7199; Percentage: 38.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1386; Denominator: 3961; Percentage: 34.99%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1606; Denominator: 3642; Percentage: 44.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="1HP" />
            <comment>
              <narrative>Numerator: 8; Denominator: 3642; Percentage: 0.22%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="89.49">
          <comment>
            <narrative>Numerator: 5294; Denominator: 5916.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="98">
            <comment>
              <narrative>Numerator: 6177; Denominator: 6303.</narrative>
            </comment>
          </target>
          <actual value="93.9">
            <comment>
              <narrative>Numerator: 6328; Denominator: 6739.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="98">
            <comment>
              <narrative>Numerator: 3087.98; Denominator: 3151.</narrative>
            </comment>
          </target>
          <actual value="90.5">
            <comment>
              <narrative>Numerator: 2840; Denominator: 3137.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="98">
            <comment>
              <narrative>Numerator: 3088.96; Denominator: 3152.</narrative>
            </comment>
          </target>
          <actual value="96.8">
            <comment>
              <narrative>Numerator: 3488; Denominator: 3602.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="98">
            <comment>
              <narrative>Numerator: 3326.12; Denominator: 3394.</narrative>
            </comment>
          </target>
          <actual value="97.5">
            <comment>
              <narrative>Numerator: 3043; Denominator: 3121.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="98">
            <comment>
              <narrative>Numerator: 6652.2; Denominator: 6788.</narrative>
            </comment>
          </target>
          <actual value="97.5">
            <comment>
              <narrative>Numerator: 6619; Denominator: 6786.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="98">
            <comment>
              <narrative>Numerator: 3326.12; Denominator: 3394.</narrative>
            </comment>
          </target>
          <actual value="97.6">
            <comment>
              <narrative>Numerator: 3576; Denominator: 3665.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="98">
            <comment>
              <narrative>Numerator: 7132.4; Denominator: 7278.</narrative>
            </comment>
          </target>
          <actual value="97.9">
            <comment>
              <narrative>Numerator: 8263; Denominator: 8438.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="98">
            <comment>
              <narrative>Numerator: 3566.22; Denominator: 3639.</narrative>
            </comment>
          </target>
          <actual value="97.4">
            <comment>
              <narrative>Numerator: 4094; Denominator: 4201.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="98">
            <comment>
              <narrative>Numerator: 3566.22; Denominator: 3639.</narrative>
            </comment>
          </target>
          <actual value="98.4">
            <comment>
              <narrative>Numerator: 4169; Denominator: 4237.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-10T16:44:39+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-BFA-T-PADS-4</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Scaling-up of high impact interventions in the fight against TB - Burkina Faso (01-Jan-2024-31-Dec-2026)</narrative>
    </title>
    <description type="1">
      <narrative>Burkina Faso, Tuberculosis, Programme d'Appui au Développement Sanitaire (PADS)</narrative>
    </description>
    <description type="2">
      <narrative>Goal: Contribuer à l’amélioration de l’état de santé de la population du Burkina Faso en réduisant le poids de la tuberculose d’ici à fin 2026./ To contribute to the improvement of the health status of the population of Burkina Faso by reducing the burden of tuberculosis by the end of 2026. Objectives: Réduire l’incidence de la tuberculose de 45 en 2021 à 36 cas/100 000 habitants en 2026 / Reduce the incidence of tuberculosis from 45 in 2021 to 36 cases/100,000 inhabitants in 2026; Reduire le taux de mortalité de la tuberculose de 6,4 en 2021 à 5,5 décès/100 000 habitants d’ici à fin 2026 / Reduce the mortality rate of tuberculosis from 6.4 in 2021 to 5.5 deaths/100,000 inhabitants by the end of 2026; Accroître le taux de succès au traitement des patients TB pharmaco sensibles de 81,5% (cohorte 2020) à au moins 90% (cohorte 2025) et ceux TB-résistante de 75% (cohorte 2020) à au moins 80% (cohorte 2025) / Increase the treatment success rate of drug-susceptible TB patients from 81.5% (2020 cohort) to at least 90% (2025 cohort) and drug-resistant TB from 75% (2020 cohort) to at least 80% (2025 cohort).</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
    </participating-org>
    <other-identifier ref="BFA-T-PADSP04" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2024-01-01" />
    <activity-date type="2" iso-date="2024-01-01" />
    <activity-date type="3" iso-date="2026-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Lilian Pedrosa</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>lilian.pedrosa@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="BF" percentage="100">
      <narrative>Burkina Faso</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="91.62">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="8.38">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="cd09d6c8-13e6-412e-a54d-84c32d99a370" percentage="2.13">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="4.9">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="2c341d5c-b46c-47a9-9aff-2700be47f75e" percentage="0.46">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
        </description>
      </budget-item>
      <budget-item code="42e7a4b3-fa75-4c16-8a4d-110492b156f4" percentage="0.5">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="85fbea77-53b5-4647-bd23-d3053191c7bb" percentage="0.06">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveillance for HIV, tuberculosis and malaria</narrative>
        </description>
      </budget-item>
      <budget-item code="1a5ab4c7-9695-4567-adb4-0a3768fa01ee" percentage="0.32">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="95211519-fdf1-4ae4-964d-27e8afa798cf" percentage="0.13">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Community-based TB/DR-TB care</narrative>
        </description>
      </budget-item>
      <budget-item code="ea39b4f6-cd94-4310-b181-394f794f9144" percentage="34.22">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB diagnosis/drug susceptibility testing (DST)</narrative>
        </description>
      </budget-item>
      <budget-item code="5b20da70-c625-405c-858b-6de52626ae46" percentage="9.3">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="99700b2a-3a9a-4855-b789-986d7a150e52" percentage="0.62">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Children and adolescents</narrative>
        </description>
      </budget-item>
      <budget-item code="9bcbb01c-6f63-414e-a67b-9a54f6bd04c0" percentage="0.15">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Miners and mining communities</narrative>
        </description>
      </budget-item>
      <budget-item code="1ed5e501-534e-43ae-bb9f-9552bd6bf461" percentage="0.34">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Mobile population (migrants/refugees/IDPs)</narrative>
        </description>
      </budget-item>
      <budget-item code="03989069-d574-46fc-9fad-200e03cde744" percentage="0.08">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="99e62de4-459a-4fc3-a5da-f5297d23736d" percentage="2.36">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - People in prisons/jails/detention centers</narrative>
        </description>
      </budget-item>
      <budget-item code="ec96c3b7-6a24-4f53-aa8c-798674357513" percentage="0.1">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Ensuring people-centered and rights-based TB services at health facilities</narrative>
        </description>
      </budget-item>
      <budget-item code="f50f08b4-b9d9-4b4a-a8b2-065858f9ce31" percentage="3.89">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="003bd5ec-d813-43cd-9bae-ec060870a2c4" percentage="31.72">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="7332ed72-b538-4ab5-b90e-f820e56c0c5b" percentage="1.17">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Infection prevention and control (IPC)</narrative>
        </description>
      </budget-item>
      <budget-item code="602586f6-9a77-484c-bf39-acc8a3151170" percentage="6.21">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Prevention</narrative>
        </description>
      </budget-item>
      <budget-item code="7c7a7505-bdfe-4146-976c-78a03ca0d545" percentage="0.67">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="c03db068-1593-4995-bf69-fe67549bd239" percentage="0.67">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Treatment and care</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">2194983.23</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">3433790.00</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">2135036.05</value>
    </budget>
    <capital-spend percentage="11.27" />
    <transaction ref="12ab7fb5-9293-4241-8d14-8c0502832b73">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-01-04" />
      <value currency="USD" value-date="2024-01-04">4074589.73</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="948f9dd2-8904-4973-8095-020b181d71bc">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-01-16" />
      <value currency="USD" value-date="2024-01-16">137628.03</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP04 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d6454826-22dc-48ea-a26a-b489ef88106c">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-02-27" />
      <value currency="USD" value-date="2024-02-27">358087.46</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="362e7afe-efc0-4cba-960e-9b0afd228742">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-02-27" />
      <value currency="USD" value-date="2024-02-27">28577.90</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="55c013b5-ee1f-48d2-b123-66d5721cab9a">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-03-21" />
      <value currency="USD" value-date="2024-03-21">393997.34</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d21d731c-8b1d-42b2-a507-a1b63e12b349">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-05-21" />
      <value currency="USD" value-date="2024-05-21">26696.93</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b3acbfcb-8b6c-4ec1-822f-a5e832ed49dd">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-05-21" />
      <value currency="USD" value-date="2024-05-21">632177.01</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="707d846a-3261-4876-9ad8-b731b995865a">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-18" />
      <value currency="USD" value-date="2024-06-18">260395.43</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP04 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3ceec7a5-4d06-4834-a34d-1866646aec43">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-08-20" />
      <value currency="USD" value-date="2024-08-20">378621.02</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP04 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9163193e-9f60-44c7-9da0-990b51765703">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-09-01" />
      <value currency="USD" value-date="2024-09-01">183.58</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7c5e6be4-2be4-4378-9020-c5219c8155f7">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-24" />
      <value currency="USD" value-date="2024-09-24">-183.58</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3843d98e-81e9-40d1-a8c9-ee0f1a825997">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-10" />
      <value currency="USD" value-date="2024-10-10">1143983.88</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="da64d115-f2fe-4168-9fdb-4d8ef4ce733a">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-21" />
      <value currency="USD" value-date="2024-11-21">188440.59</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP04 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ce5cff5d-f024-4c4e-8f63-4a7db3db13c8">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-12-04" />
      <value currency="USD" value-date="2024-12-04">989.36</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="41464ba7-f85d-4028-8f72-c7edec5f3308">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-12-16" />
      <value currency="USD" value-date="2024-12-16">-989.36</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="637cfedf-1e01-4d23-b8a7-559061647fb7">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-18" />
      <value currency="USD" value-date="2024-12-18">73987.73</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="50a1166f-db19-4b03-8cae-ffc35d905a3f">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-03-01" />
      <value currency="USD" value-date="2025-03-01">3151.03</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6b70584b-7147-44b1-8eb2-b092c6575f22">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-03-07" />
      <value currency="USD" value-date="2025-03-07">22564.38</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c57e806d-eeef-48ce-9267-3958f4612adf">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-03-26" />
      <value currency="USD" value-date="2025-03-26">-22564.38</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="023ad450-a776-43a6-8016-125f210c7b1c">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-03-26" />
      <value currency="USD" value-date="2025-03-26">-3151.03</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="21682c39-2e01-4a4c-928e-c3d0b52cf3df">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-02" />
      <value currency="USD" value-date="2025-05-02">1817733.17</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="551246e8-aa72-441c-81d7-e77d5d6121bd">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-02" />
      <value currency="USD" value-date="2025-05-02">-451996.40</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="797530f3-c584-44ef-9daf-a30dbb7b43a3">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-05-06" />
      <value currency="USD" value-date="2025-05-06">620786.63</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bc1c0310-d83c-4d58-bef7-a4584a8943cb">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-06-01" />
      <value currency="USD" value-date="2025-06-01">31212.29</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cd0442fe-c474-4b96-8438-c5d46daeaf17">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-06" />
      <value currency="USD" value-date="2025-06-06">-31212.29</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="247f4e1d-0234-4592-8a8a-0f7c10247483">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-27" />
      <value currency="USD" value-date="2025-06-27">697365.13</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d4d88af6-894e-4ee7-9d97-ea65b25825ef">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">697365.13</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="232e9150-1803-4a6a-b88c-edf589db2f55">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-01" />
      <value currency="USD" value-date="2025-07-01">7166.89</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="13222019-3c39-4bdc-973c-f5500f3f26ef">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-08-05" />
      <value currency="USD" value-date="2025-08-05">7142.61</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c1bdf7eb-b191-4d44-8dff-831366c3118e">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-09-01" />
      <value currency="USD" value-date="2025-09-01">25487.15</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5cb4ac2f-340f-4d1e-848d-0f2683af326a">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-09-10" />
      <value currency="USD" value-date="2025-09-10">-25487.15</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="105c47c6-67d8-4e7e-ba6a-62f6c696193b">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-04" />
      <value currency="USD" value-date="2025-11-04">22079.13</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="801f4e3d-c7d9-478b-92af-b4a2173d869c">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-27" />
      <value currency="USD" value-date="2025-11-27">207428.53</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b614448a-e0cb-44cd-b37e-14786e299df0">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-12-05" />
      <value currency="USD" value-date="2025-12-05">4221.54</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="14a8d0e3-00d9-4b58-9ef5-f373fe045df8">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-12-10" />
      <value currency="USD" value-date="2025-12-10">1071.10</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e7ec9ec8-f261-46cb-956e-ee190ea28214">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-16" />
      <value currency="USD" value-date="2025-12-16">-4221.54</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b850269c-27cd-4fae-93b5-33edc930558f">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-18" />
      <value currency="USD" value-date="2025-12-18">-1071.10</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6626c602-41d6-442a-bae8-c030234acb79">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-03-09" />
      <value currency="USD" value-date="2026-03-09">88.60</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7922f385-b392-494d-be27-92aad1f1e374">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-17" />
      <value currency="USD" value-date="2026-03-17">-88.60</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6afea8ce-a9eb-4328-9b8c-bb52bb69d3ed">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-01" />
      <value currency="USD" value-date="2026-04-01">893508.76</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="35d43bcc-0030-46c7-92a4-b5a648fa4c6e">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-01" />
      <value currency="USD" value-date="2026-04-01">11821.66</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1f1ba043-5b2d-4788-b452-e8495fa0ada0">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-15" />
      <value currency="USD" value-date="2026-04-15">98567.98</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="021ad077-fc37-4b64-91c3-1bfcd02b4ad9">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-21" />
      <value currency="USD" value-date="2026-04-21">187399.23</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="84afd6bf-dd43-4d9a-87d3-6b603439260c">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-06-04" />
      <value currency="USD" value-date="2026-06-04">18742.09</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c0109024-08c3-442e-8002-138551f84bb9">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-18" />
      <value currency="USD" value-date="2026-06-18">835287.82</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="753aba0c-a12a-4e41-b928-cda46539833d">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-18" />
      <value currency="USD" value-date="2026-06-18">-67828.28</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="119de56a-7c02-482f-843f-b59912f2eb42">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-19" />
      <value currency="USD" value-date="2026-06-19">-18742.09</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2b94fa55-0426-45e8-a8c4-ff005461d6f5">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-23" />
      <value currency="USD" value-date="2026-06-23">437871.03</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP04 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f2fdafb0-1f72-4f23-a5f0-e22b4127b6f7">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-04" />
      <value currency="USD" value-date="2026-08-04">33662.53</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="10d5ba23-8e8b-454b-abc0-463d6cbf1e34">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-25" />
      <value currency="USD" value-date="2026-08-25">1561.77</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="67e928be-abfc-4ce8-9633-ef08e2572a21">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-09-04" />
      <value currency="USD" value-date="2026-09-04">24675.97</value>
      <description>
        <narrative>Funds returned to the Global Fund from BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c41f4dfa-26d1-4932-96f0-9919aa331e84">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-14" />
      <value currency="USD" value-date="2026-09-14">-24675.97</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c42debb0-95b9-482c-90b9-b55f92b5eb93">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-05" />
      <value currency="USD" value-date="2026-10-05">-73636.25</value>
      <description>
        <narrative>Global Fund commitment to BFA-T-PADSP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4758e49f-2dfd-4424-9a31-b17d51799552">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-12" />
      <value currency="USD" value-date="2026-10-12">14875.29</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c0b2ee22-ad5d-495e-8d3d-11013f2b02bc">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-27" />
      <value currency="USD" value-date="2026-10-27">26279.59</value>
      <description>
        <narrative>Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="BFA-T-PADSP04-EXP-20241231">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">2194983.23</value>
      <description>
        <narrative>Expenditure reported by Programme d'Appui au Développement Sanitaire (PADS) for BFA-T-PADSP04, Jan 2024 to Dec 2024.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
    </transaction>
    <transaction ref="BFA-T-PADSP04-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">2554792.00</value>
      <description>
        <narrative>Expenditure reported by Programme d'Appui au Développement Sanitaire (PADS) for BFA-T-PADSP04, Jan 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Programme d'Appui au Développement Sanitaire (PADS)</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/BFA-T-PADS" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-10" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/BFA/2023/Multicomponent/en/BFA-Z_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 1 - Multicomponent - Burkina Faso - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1537-BFA-Z.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2023-03-30" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/BFA/2023/Multicomponent/fr/BFA-Z_FundingRequest_1_fr.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 1 - Multicomponent - Burkina Faso - Français</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1537-BFA-Z.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="fr" />
      <document-date iso-date="2023-03-30" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="77" />
        <baseline year="2022" iso-date="2022-12-31" value="77">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="77">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="0">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="0">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="13">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="13">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="64">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="64">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="71">
          <dimension name="HIV status" value="Negative" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="71">
          <dimension name="HIV status" value="Negative" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="2">
          <dimension name="HIV status" value="Positive" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="2">
          <dimension name="HIV status" value="Positive" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="2">
          <dimension name="HIV status" value="Unknown" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="2">
          <dimension name="HIV status" value="Unknown" />
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="51" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="101" />
          <actual value="121" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="50" />
          <actual value="79" />
          <actual value="54">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="3">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="11">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="46">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="47">
            <dimension name="HIV status" value="Negative" />
          </actual>
          <actual value="6">
            <dimension name="HIV status" value="Positive" />
          </actual>
          <actual value="1">
            <dimension name="HIV status" value="Unknown" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="53" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="105" />
          <actual value="85" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="52" />
          <actual value="41" />
          <actual value="38">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="3">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="8">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="33">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="0">
            <dimension name="HIV status" value="Negative" />
          </actual>
          <actual value="5">
            <dimension name="HIV status" value="Positive" />
          </actual>
          <actual value="0">
            <dimension name="HIV status" value="Unknown" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="54" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="54" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 66; Denominator: 77; Percentage: 85.71%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 68; Denominator: 77; Percentage: 88.31%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 68; Denominator: 77; Percentage: 88.31%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Denominator: 77; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Denominator: 77; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 11; Denominator: 77; Percentage: 14.29%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 11; Denominator: 77; Percentage: 14.29%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 2; Denominator: 77; Percentage: 2.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 2; Denominator: 77; Percentage: 2.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 57; Denominator: 77; Percentage: 74.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 57; Denominator: 77; Percentage: 74.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 66; Denominator: 77; Percentage: 85.71%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 66; Denominator: 77; Percentage: 85.71%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 106; Denominator: 121; Percentage: 87.6%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 64; Denominator: 79; Percentage: 81.01%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 48; Denominator: 54; Percentage: 88.89%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 3; Denominator: 3; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 10; Denominator: 51; Percentage: 19.61%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 3.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 41; Denominator: 51; Percentage: 80.39%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 48.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 79; Denominator: 85; Percentage: 92.94%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 41; Denominator: 41; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 37; Denominator: 38; Percentage: 97.37%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 3; Denominator: 3; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 9; Denominator: 9; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 31; Denominator: 32; Percentage: 96.88%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 44; Denominator: 82; Percentage: 53.66%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 44; Denominator: 82; Percentage: 53.66%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 44; Denominator: 82; Percentage: 53.66%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Denominator: 82; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Denominator: 82; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 7; Denominator: 82; Percentage: 8.54%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 7; Denominator: 82; Percentage: 8.54%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 2; Denominator: 82; Percentage: 2.44%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 2; Denominator: 82; Percentage: 2.44%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 37; Denominator: 82; Percentage: 45.12%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 37; Denominator: 82; Percentage: 45.12%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 39; Denominator: 82; Percentage: 47.56%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 39; Denominator: 82; Percentage: 47.56%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 5; Denominator: 82; Percentage: 6.1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 5; Denominator: 82; Percentage: 6.1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Private" />
          <comment>
            <narrative>Numerator: 5; Denominator: 82; Percentage: 6.1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Private" />
          <comment>
            <narrative>Numerator: 5; Denominator: 82; Percentage: 6.1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 39; Denominator: 82; Percentage: 47.56%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 39; Denominator: 82; Percentage: 47.56%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 42; Denominator: 82; Percentage: 51.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 42; Denominator: 82; Percentage: 51.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 0; Denominator: 82; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 0; Denominator: 82; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 73.4%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 73.4%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 69; Denominator: 112; Percentage: 61.61%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 73.4%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 26; Denominator: 42; Percentage: 61.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 28; Denominator: 56; Percentage: 50%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1; Denominator: 1; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 8; Denominator: 12; Percentage: 66.67%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 1.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 21; Denominator: 45; Percentage: 46.67%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 28; Denominator: 49; Percentage: 57.14%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 1; Denominator: 5; Percentage: 20%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Private" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 29; Denominator: 57; Percentage: 50.88%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 28.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 0; Denominator: 2.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 76.8%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 48; Denominator: 71; Percentage: 67.61%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 76.77%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 76.77%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 23; Denominator: 34; Percentage: 67.65%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 1; Denominator: 4; Percentage: 25%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Private" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 23; Denominator: 34; Percentage: 67.65%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 80.39%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 80.39%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with TB (all forms) notified among key affected populations/high risk groups (other than prisoners); *includes only those with new and relapse</narrative>
      </title>
      <description>
        <narrative>Module: Key and vulnerable populations (KVP) - TB/DR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people with TB (all forms) notified among key affected populations/high risk groups (other than prisoners); *includes only those with new and relapse</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="250" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="563" />
          <actual value="862" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="282" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="281" />
          <actual value="366" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="423" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="845" />
          <actual value="816" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="422" />
          <actual value="417" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="634" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="634" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: Key and vulnerable populations (KVP) - TB/DR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="39" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="23" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="46" />
          <actual value="91" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="23" />
          <actual value="74" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="56" />
          <actual value="97" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="28" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="28" />
          <actual value="72" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="39" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="39" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="7320" />
        <baseline year="2022" iso-date="2022-12-31" value="7078">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="7078">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="242">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="242">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="4927">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="4927">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="1849">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="1849">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="5471">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="5471">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="6751">
          <dimension name="HIV status" value="Negative" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="6751">
          <dimension name="HIV status" value="Negative" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="395">
          <dimension name="HIV status" value="Positive" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="395">
          <dimension name="HIV status" value="Positive" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="174">
          <dimension name="HIV status" value="Unknown" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="174">
          <dimension name="HIV status" value="Unknown" />
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="3966" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="7931" />
          <actual value="9308" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="3965" />
          <actual value="4572" />
          <actual value="4373">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="199">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="3102">
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
          </actual>
          <actual value="1234">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="3338">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="3995">
            <dimension name="HIV status" value="Negative" />
          </actual>
          <actual value="208">
            <dimension name="HIV status" value="Positive" />
          </actual>
          <actual value="74">
            <dimension name="HIV status" value="Unknown" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="8405" />
          <actual value="10304" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="4203" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="4202" />
          <actual value="5194" />
          <actual value="4966">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="228">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="3596">
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
          </actual>
          <actual value="1261">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="3933">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="4640">
            <dimension name="HIV status" value="Negative" />
          </actual>
          <actual value="259">
            <dimension name="HIV status" value="Positive" />
          </actual>
          <actual value="17">
            <dimension name="HIV status" value="Unknown" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="4382" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="4381" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 3903; Denominator: 7320; Percentage: 53.32%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Private" />
          <comment>
            <narrative>Numerator: 190; Denominator: 7320; Percentage: 2.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Private" />
          <comment>
            <narrative>Numerator: 190; Denominator: 7320; Percentage: 2.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 3713; Denominator: 7320; Percentage: 50.72%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 3713; Denominator: 7320; Percentage: 50.72%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 70%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 70%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5370; Denominator: 9308; Percentage: 57.69%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 70%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2592; Denominator: 4572; Percentage: 56.69%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Private" />
            <comment>
              <narrative>Numerator: 139.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 2453.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 80%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 80%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7001; Denominator: 10304; Percentage: 67.94%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 80%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3735; Denominator: 5194; Percentage: 71.91%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Private" />
            <comment>
              <narrative>Numerator: 114.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 3621.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 90%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 90%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="31.49">
          <comment>
            <narrative>Numerator: 2305; Denominator: 7320.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="35" />
          <actual value="11.03">
            <comment>
              <narrative>Numerator: 1027; Denominator: 9308.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="35" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="35" />
          <actual value="8.88">
            <comment>
              <narrative>Numerator: 406; Denominator: 4572.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="40" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="40" />
          <actual value="9.94">
            <comment>
              <narrative>Numerator: 1024; Denominator: 10304.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="40" />
          <actual value="12.4">
            <comment>
              <narrative>Numerator: 644; Denominator: 5194.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="40" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="40" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="81.31">
          <comment>
            <narrative>Numerator: 5461; Denominator: 6716.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="90" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="90" />
          <actual value="81.03">
            <comment>
              <narrative>Numerator: 6883; Denominator: 8494.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="90" />
          <actual value="80.88">
            <comment>
              <narrative>Numerator: 3931; Denominator: 4860.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="91" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="91" />
          <actual value="84.29">
            <comment>
              <narrative>Numerator: 7780; Denominator: 9230.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="91" />
          <actual value="85.8">
            <comment>
              <narrative>Numerator: 3929; Denominator: 4579.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="92" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="92" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/DR-TB Prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="1567" />
        <baseline year="2022" iso-date="2022-12-31" value="1567">
          <dimension name="Age" value="&lt;5" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="1560">
          <dimension name="HIV status" value="Negative" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="7">
          <dimension name="HIV status" value="Positive" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="0">
          <dimension name="HIV status" value="Unknown" />
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="2954" />
          <actual value="1551" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="1477" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="1477" />
          <actual value="649" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="1596" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="3192" />
          <actual value="1673" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="1596" />
          <actual value="833" />
          <actual value="1673">
            <dimension name="Age" value="&lt;5" />
          </actual>
          <actual value="814">
            <dimension name="HIV status" value="Negative" />
          </actual>
          <actual value="19">
            <dimension name="HIV status" value="Positive" />
          </actual>
          <actual value="0">
            <dimension name="HIV status" value="Unknown" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="1764" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="1764" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="97.72">
          <comment>
            <narrative>Numerator: 386; Denominator: 395.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100" />
          <actual value="99.57">
            <comment>
              <narrative>Numerator: 466; Denominator: 468.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100" />
          <actual value="97.12">
            <comment>
              <narrative>Numerator: 202; Denominator: 208.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100" />
          <actual value="99.23">
            <comment>
              <narrative>Numerator: 518; Denominator: 522.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100" />
          <actual value="99.61">
            <comment>
              <narrative>Numerator: 258; Denominator: 259.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="100" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 1665; Denominator: 78511; Percentage: 2.12%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 588; Denominator: 3802; Percentage: 15.47%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 588; Denominator: 3802; Percentage: 15.47%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="TPT regimen" value="1HP" />
          <comment>
            <narrative>Numerator: 12; Denominator: 3802; Percentage: 0.32%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="TPT regimen" value="1HP" />
          <comment>
            <narrative>Numerator: 12; Denominator: 3802; Percentage: 0.32%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="TPT regimen" value="3HP" />
          <comment>
            <narrative>Numerator: 478; Denominator: 3802; Percentage: 12.57%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="TPT regimen" value="3HP" />
          <comment>
            <narrative>Numerator: 478; Denominator: 3802; Percentage: 12.57%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="TPT regimen" value="3RH" />
          <comment>
            <narrative>Numerator: 75; Denominator: 3802; Percentage: 1.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="TPT regimen" value="3RH" />
          <comment>
            <narrative>Numerator: 75; Denominator: 3802; Percentage: 1.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="TPT regimen" value="6H" />
          <comment>
            <narrative>Numerator: 23; Denominator: 3802; Percentage: 0.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="TPT regimen" value="6H" />
          <comment>
            <narrative>Numerator: 23; Denominator: 3802; Percentage: 0.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 403; Denominator: 3802; Percentage: 10.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 403; Denominator: 3802; Percentage: 10.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 185; Denominator: 3802; Percentage: 4.87%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 185; Denominator: 3802; Percentage: 4.87%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 10770; Denominator: 86600; Percentage: 12.4%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 9338; Denominator: 59908; Percentage: 15.59%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 5385; Denominator: 86600; Percentage: 6.22%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 5385; Denominator: 86600; Percentage: 6.22%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5355; Denominator: 59908; Percentage: 8.94%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 5201.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="1HP" />
            <comment>
              <narrative>Numerator: 639.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="3HP" />
            <comment>
              <narrative>Numerator: 3622.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="3RH" />
            <comment>
              <narrative>Numerator: 733.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="6H" />
            <comment>
              <narrative>Numerator: 361.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 3747.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1608.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 9127; Denominator: 86392; Percentage: 10.56%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 18254; Denominator: 86392; Percentage: 21.1%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 13817; Denominator: 87534; Percentage: 15.78%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 9127; Denominator: 86392; Percentage: 10.56%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7400; Denominator: 87534; Percentage: 8.45%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 13548.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="1HP" />
            <comment>
              <narrative>Numerator: 304.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="3HP" />
            <comment>
              <narrative>Numerator: 4451.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="3RH" />
            <comment>
              <narrative>Numerator: 2026.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="6H" />
            <comment>
              <narrative>Numerator: 619.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 9946.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 3871.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 9580; Denominator: 86360; Percentage: 11.09%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 9579; Denominator: 86360; Percentage: 11.09%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV newly initiated on ART who were screened for TB</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV newly initiated on ART who were screened for TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 7945; Denominator: 7945; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 7406; Denominator: 7406; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 7406; Denominator: 7406; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 283; Denominator: 283; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 283; Denominator: 283; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 256; Denominator: 256; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 256; Denominator: 256; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 5321; Denominator: 5321; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 5321; Denominator: 5321; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2524; Denominator: 2624; Percentage: 96.19%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2524; Denominator: 2624; Percentage: 96.19%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 22168; Denominator: 7726; Percentage: 286.93%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8085; Denominator: 3877; Percentage: 208.54%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 7523.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 368.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 162.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 5384.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2669.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6779; Denominator: 6853; Percentage: 98.92%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3507; Denominator: 3557; Percentage: 98.59%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 6426.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 141.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 212.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 4603.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2176.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 7146; Denominator: 7320; Percentage: 97.62%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 6751; Denominator: 7320; Percentage: 92.23%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 6751; Denominator: 7320; Percentage: 92.23%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 395; Denominator: 7320; Percentage: 5.4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 395; Denominator: 7320; Percentage: 5.4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 174; Denominator: 7320; Percentage: 2.38%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 174; Denominator: 7320; Percentage: 2.38%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 98%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 98%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8792; Denominator: 9308; Percentage: 94.46%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 98%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4277; Denominator: 4572; Percentage: 93.55%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 3995.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 208.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 74.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 98%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 98%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 10154; Denominator: 10304; Percentage: 98.54%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 98%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5177; Denominator: 5194; Percentage: 99.67%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 4640.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 259.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 278.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 99%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 99%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>